%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Davide Croce, Adriano Lazzarin, Giuliano Rizzardini, Nicola Gianotti, Francesca Scolari, Emanuela Foglia, Elisabetta Garagiola, Elena Ricci, Teresa Bini, Tiziana Quirino, Paolo Viganò, Tiziana Re, Antonella D’Arminio Monforte, Paolo Bonfanti
HIV Clinical Pathway: A New Approach to Combine Guidelines and Sustainability of Anti-Retroviral Treatment in Italy
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 11 0 R/Annots 12 0 R/Contents 13 0 R/TrimBox[0 0 612 792]>>
endobj
12 0 obj
[14 0 R 15 0 R 16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 32 0 R]
endobj
14 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168399.ref001)>>
endobj
15 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168399.ref002)>>
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168399.ref003)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168399.ref004)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168399.ref005)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168399.ref006)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168399.ref007)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168399.ref008)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168399.ref005)>>
endobj
23 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168399.ref006)>>
endobj
24 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168399.ref007)>>
endobj
25 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168399.ref009)>>
endobj
26 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168399.ref010)>>
endobj
27 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168399.ref011)>>
endobj
28 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168399.ref012)>>
endobj
29 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168399.ref013)>>
endobj
30 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168399.ref014)>>
endobj
31 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168399.ref015)>>
endobj
32 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168399.ref016)>>
endobj
13 0 obj
[33 0 R 34 0 R 35 0 R 36 0 R 37 0 R 38 0 R 39 0 R 40 0 R 41 0 R 42 0 R 43 0 R 44 0 R 45 0 R 46 0 R 47 0 R 48 0 R 49 0 R 50 0 R]
endobj
33 0 obj
<>stream
q
0.83 0.64 0.02 0 k
272.2961 662.0031 m
277.0016 662.0031 l
h
f*
360.5102 649.0205 m
365.2724 649.0205 l
h
f*
274.6205 622.9984 m
279.326 622.9984 l
h
f*
522.085 571.011 m
526.8472 571.011 l
h
f*
514.4315 558.0283 m
519.1937 558.0283 l
h
f*
253.3039 532.0063 m
258.0661 532.0063 l
h
f*
203.4142 505.9843 m
208.1764 505.9843 l
h
f*
210.3874 505.9843 m
215.1496 505.9843 l
h
f*
439.4268 480.0189 m
444.189 480.0189 l
h
f*
446.4567 480.0189 m
451.2189 480.0189 l
h
f*
453.4866 480.0189 m
458.1921 480.0189 l
h
f*
422.589 389.0268 m
427.3512 389.0268 l
h
f*
444.4157 363.0047 m
453.9402 363.0047 l
h
f*
456.1512 363.0047 m
465.6756 363.0047 l
h
f*
524.3528 259.0299 m
533.8772 259.0299 l
h
f*
536.1449 259.0299 m
545.6693 259.0299 l
h
f*
547.937 259.0299 m
557.4047 259.0299 l
h
f*
505.7575 245.9906 m
515.2819 245.9906 l
h
f*
388.1197 233.0079 m
397.5874 233.0079 l
h
f*
0 g
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 706.0535 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Introduction)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 689.1023 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(The)Tj
1.7801 0 Td
(introduction)Tj
5.3121 0 Td
(of)Tj
1.0148 0 Td
(Highly)Tj
2.948 0 Td
(Active)Tj
2.7723 0 Td
(Anti-retroviral)Tj
6.1171 0 Td
(Therapy)Tj
3.5546 0 Td
(\(HAART\))Tj
4.269 0 Td
(in)Tj
1.0374 0 Td
(clinical)Tj
3.0784 0 Td
(practice)Tj
3.3789 0 Td
(has)Tj
-35.2627 -1.3039 Td
(improved)Tj
4.1045 0 Td
(the)Tj
1.474 0 Td
(survival)Tj
3.3335 0 Td
(of)Tj
1.0148 0 Td
(people)Tj
2.8573 0 Td
(living)Tj
2.4661 0 Td
(with)Tj
2.0013 0 Td
(HIV)Tj
2.0182 0 Td
(\(PLHIV\))Tj
3.8041 0 Td
(and)Tj
1.7291 0 Td
(substantially)Tj
5.2044 0 Td
(decreased)Tj
4.1329 0 Td
(morbid-)Tj
-34.1402 -1.2982 Td
(ity)Tj
1.2415 0 Td
(and)Tj
1.7291 0 Td
(mortality)Tj
3.9175 0 Td
([)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
(].)Tj
1.5987 0 Td
(Life)Tj
1.7348 0 Td
(expectancy)Tj
4.6318 0 Td
(for)Tj
1.389 0 Td
(PLHIV)Tj
3.1181 0 Td
(treated)Tj
2.999 0 Td
(with)Tj
1.9956 0 Td
(ART)Tj
2.1373 0 Td
(has)Tj
1.542 0 Td
(increased,)Tj
4.2236 0 Td
(transforming)Tj
-32.258 -1.2983 Td
(HIV)Tj
2.0182 0 Td
(infection)Tj
3.7927 0 Td
(into)Tj
1.8425 0 Td
(a)Tj
0.652 0 Td
(chronic)Tj
3.2882 0 Td
(condition)Tj
4.1159 0 Td
([)Tj
0.83 0.64 0.02 0 k
(2)Tj
0 g
(].)Tj
1.6044 0 Td
(Consequently,)Tj
5.9527 0 Td
(healthcare)Tj
4.3313 0 Td
(expenditure)Tj
5.0116 0 Td
(\(i.e.)Tj
1.7008 0 Td
(drugs,)Tj
-34.3103 -1.3039 Td
(diagnostic)Tj
4.3199 0 Td
(exams,)Tj
2.948 0 Td
(specialist)Tj
3.8154 0 Td
(visits,)Tj
2.4548 0 Td
(hospitalisations\))Tj
6.7635 0 Td
(directly)Tj
3.2314 0 Td
(related)Tj
2.948 0 Td
(to)Tj
1.0262 0 Td
(the)Tj
1.4683 0 Td
(management)Tj
5.4312 0 Td
(of)Tj
-34.4067 -1.2983 Td
(PLHIV)Tj
3.118 0 Td
(increased)Tj
4.0025 0 Td
([)Tj
0.83 0.64 0.02 0 k
(3)Tj
0 g
(],)Tj
1.5988 0 Td
(both)Tj
2.0579 0 Td
(at)Tj
0.9524 0 Td
(individual)Tj
4.2917 0 Td
(and)Tj
1.7291 0 Td
(at)Tj
0.9524 0 Td
(population)Tj
4.5921 0 Td
(level.)Tj
2.2394 0 Td
(This)Tj
1.9842 0 Td
(led)Tj
1.4173 0 Td
(the)Tj
1.4684 0 Td
(payers)Tj
2.7836 0 Td
(to)Tj
1.0261 0 Td
(design)Tj
-34.2139 -1.2982 Td
(solutions)Tj
3.8437 0 Td
(to)Tj
1.0261 0 Td
(reduce)Tj
2.914 0 Td
(public)Tj
2.7099 0 Td
(healthcare)Tj
4.3314 0 Td
(expenditure,)Tj
5.2383 0 Td
(in)Tj
1.0375 0 Td
(order)Tj
2.4208 0 Td
(to)Tj
1.0205 0 Td
(maintain)Tj
3.838 0 Td
(the)Tj
1.4741 0 Td
(sustainability)Tj
5.4878 0 Td
(for)Tj
-35.3421 -1.304 Td
(the)Tj
1.4683 0 Td
(Healthcare)Tj
4.5694 0 Td
(Services,)Tj
3.6453 0 Td
(at)Tj
0.9525 0 Td
(the)Tj
1.4683 0 Td
(same)Tj
2.262 0 Td
(time)Tj
2.024 0 Td
(preserving)Tj
4.4277 0 Td
(the)Tj
1.4683 0 Td
(highest)Tj
3.0897 0 Td
(medical)Tj
3.3619 0 Td
(care)Tj
1.8709 0 Td
(standards.)Tj
-29.4121 -1.2982 Td
(Recent)Tj
2.9593 0 Td
(publications)Tj
5.125 0 Td
(reported)Tj
3.6624 0 Td
(that)Tj
1.7801 0 Td
(Healthcare)Tj
4.5694 0 Td
(Services)Tj
3.4186 0 Td
(worldwide)Tj
4.456 0 Td
(called)Tj
2.5228 0 Td
(for)Tj
1.389 0 Td
(Clinical)Tj
3.3165 0 Td
(Gover-)Tj
-34.3953 -1.2983 Td
(nance)Tj
2.5965 0 Td
(\(CG\))Tj
2.279 0 Td
(tools)Tj
2.1373 0 Td
(to)Tj
1.0262 0 Td
(ensure)Tj
2.8743 0 Td
(quality)Tj
2.9593 0 Td
(and)Tj
1.7291 0 Td
(sustainability)Tj
5.4936 0 Td
(of)Tj
1.0147 0 Td
(HIV)Tj
2.0183 0 Td
(treatment)Tj
4.1386 0 Td
(and)Tj
1.7291 0 Td
(care)Tj
1.8708 0 Td
([)Tj
0.83 0.64 0.02 0 k
(4)Tj
0 g
(].)Tj
1.6044 0 Td
(In)Tj
1.1055 0 Td
(partic-)Tj
-34.5767 -1.2983 Td
(ular,)Tj
2.0239 0 Td
(the)Tj
1.4683 0 Td
(most)Tj
2.2054 0 Td
(relevant)Tj
3.4242 0 Td
(strategies)Tj
3.9231 0 Td
(were:)Tj
2.3471 0 Td
(\(i\))Tj
1.1678 0 Td
(the)Tj
1.4684 0 Td
(rational)Tj
3.3278 0 Td
(use)Tj
1.5307 0 Td
(of)Tj
1.0148 0 Td
(diagnostic)Tj
4.32 0 Td
(testing)Tj
2.88 0 Td
([)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(];)Tj
1.5987 0 Td
(\(ii\))Tj
1.4343 0 Td
(the)Tj
-34.1345 -1.3039 Td
(implementation)Tj
6.6386 0 Td
(of)Tj
1.0148 0 Td
(health)Tj
2.6759 0 Td
(economics)Tj
4.5014 0 Td
(approach,)Tj
4.1783 0 Td
(in)Tj
1.0318 0 Td
(particular)Tj
4.1158 0 Td
(the)Tj
1.4684 0 Td
(definition)Tj
4.1612 0 Td
(of)Tj
1.0148 0 Td
(cost-effective-)Tj
-30.801 -1.2982 Td
(ness)Tj
1.9105 0 Td
(criteria)Tj
3.0784 0 Td
([)Tj
0.83 0.64 0.02 0 k
(6)Tj
0 g
(],)Tj
1.5987 0 Td
(to)Tj
1.0262 0 Td
(compare)Tj
3.719 0 Td
(the)Tj
1.4683 0 Td
(performance)Tj
5.3461 0 Td
(of)Tj
1.0148 0 Td
(different)Tj
3.6567 0 Td
(therapeutic)Tj
4.7338 0 Td
(alternatives,)Tj
5.006 0 Td
(in)Tj
1.0375 0 Td
(addition)Tj
-33.596 -1.2983 Td
(to)Tj
1.0261 0 Td
(an)Tj
1.2019 0 Td
(economic)Tj
4.1385 0 Td
(forecast)Tj
3.3279 0 Td
(concerning)Tj
4.7451 0 Td
(the)Tj
1.4684 0 Td
(overall)Tj
2.9026 0 Td
(budget)Tj
2.9707 0 Td
(devoted)Tj
3.3846 0 Td
(to)Tj
1.0261 0 Td
(PLHIV)Tj
3.1181 0 Td
(treatment)Tj
4.1329 0 Td
(and)Tj
1.7291 0 Td
(care)Tj
-35.172 -1.3039 Td
([)Tj
0.83 0.64 0.02 0 k
(7)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(8)Tj
0 g
(];)Tj
2.3017 0 Td
(\(iii\))Tj
1.7007 0 Td
(the)Tj
1.4684 0 Td
(use)Tj
1.5307 0 Td
(of)Tj
1.0148 0 Td
(protease)Tj
3.5603 0 Td
(inhibitor)Tj
3.7814 0 Td
(\(PI\))Tj
1.7971 0 Td
(mono)Tj
2.6022 0 Td
(and)Tj
1.7291 0 Td
(dual)Tj
1.9559 0 Td
(therapies,)Tj
4.0705 0 Td
(the)Tj
1.4684 0 Td
(administration)Tj
6.1681 0 Td
(of)Tj
-35.1493 -1.2983 Td
(Non-Nucleoside)Tj
6.8031 0 Td
(Reverse-Transcriptase)Tj
9.0708 0 Td
(Inhibitors)Tj
4.2179 0 Td
(\(NNRTI\)-based,)Tj
6.7748 0 Td
(instead)Tj
3.0784 0 Td
(of)Tj
1.0148 0 Td
(PI-based)Tj
3.7247 0 Td
(regi-)Tj
-34.6845 -1.2982 Td
(mens,)Tj
2.5965 0 Td
(and)Tj
1.7291 0 Td
(the)Tj
1.4683 0 Td
(introduction)Tj
5.3178 0 Td
(of)Tj
1.0148 0 Td
(generic)Tj
3.1408 0 Td
(anti-retroviral)Tj
5.862 0 Td
(drugs)Tj
2.4718 0 Td
([)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(6)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(7)Tj
0 g
(].)Tj
3.0047 0 Td
(All)Tj
1.3946 0 Td
(these)Tj
2.2564 0 Td
(strategies)Tj
3.9231 0 Td
(could)Tj
-34.1799 -1.304 Td
(impact)Tj
2.9763 0 Td
(on)Tj
1.2756 0 Td
(the)Tj
1.474 0 Td
(performances)Tj
5.7089 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(Hospitals)Tj
3.9798 0 Td
(Units)Tj
2.4321 0 Td
(and)Tj
1.7291 0 Td
(clinicians,)Tj
4.2293 0 Td
(taking)Tj
2.7326 0 Td
(in)Tj
1.0318 0 Td
(charge)Tj
2.8686 0 Td
(PLHIV)Tj
3.1181 0 Td
(and)Tj
-36.0394 -1.2982 Td
(dealing)Tj
3.1294 0 Td
(with)Tj
2.0012 0 Td
(the)Tj
1.4684 0 Td
(problem)Tj
3.6113 0 Td
(of)Tj
1.0148 0 Td
(HIV,)Tj
2.245 0 Td
(modifying)Tj
4.3653 0 Td
(the)Tj
1.474 0 Td
(approach)Tj
3.9515 0 Td
(to)Tj
1.0205 0 Td
(the)Tj
1.474 0 Td
(patients.)Tj
-24.5592 -1.2983 Td
(In)Tj
1.1111 0 Td
(Italy,)Tj
2.2167 0 Td
(the)Tj
1.474 0 Td
(access)Tj
2.6419 0 Td
(to)Tj
1.0261 0 Td
(HIV)Tj
2.024 0 Td
(treatment,)Tj
4.3596 0 Td
(related)Tj
2.948 0 Td
(diagnostic)Tj
4.3143 0 Td
(exams,)Tj
2.9537 0 Td
(specialist)Tj
3.8154 0 Td
(visits)Tj
2.228 0 Td
(and)Tj
1.7348 0 Td
(hospita-)Tj
-34.0438 -1.2983 Td
(lisations,)Tj
3.736 0 Td
(is)Tj
0.8447 0 Td
(completely)Tj
4.5808 0 Td
(free)Tj
1.7291 0 Td
(for)Tj
1.3833 0 Td
(the)Tj
1.4683 0 Td
(patients)Tj
3.3676 0 Td
(and)Tj
1.7348 0 Td
(delivered)Tj
3.8834 0 Td
(mainly)Tj
2.9877 0 Td
(by)Tj
1.1849 0 Td
(hospitals,)Tj
3.9628 0 Td
(through)Tj
3.4469 0 Td
(Infec-)Tj
-34.3103 -1.3039 Td
(tious)Tj
2.1769 0 Td
(Diseases)Tj
3.5887 0 Td
(Units.)Tj
2.6589 0 Td
(Each)Tj
2.1713 0 Td
(Regional)Tj
3.736 0 Td
(Health)Tj
2.914 0 Td
(Service)Tj
3.0614 0 Td
(\(RHS\)at)Tj
4.0139 0 Td
(the)Tj
1.4683 0 Td
(decentralised)Tj
5.4992 0 Td
(levelis)Tj
-31.2886 -1.2982 Td
(responsible)Tj
4.7508 0 Td
(for)Tj
1.389 0 Td
(delivering)Tj
4.2122 0 Td
(services)Tj
3.3052 0 Td
(for)Tj
1.389 0 Td
(prevention,)Tj
4.8018 0 Td
(hospital)Tj
3.3789 0 Td
(care)Tj
1.8765 0 Td
(and)Tj
1.7291 0 Td
(community)Tj
4.8869 0 Td
(care,)Tj
2.0977 0 Td
(and)Tj
1.7291 0 Td
(cov-)Tj
-35.5462 -1.2983 Td
(ers)Tj
1.3719 0 Td
(pharmaceutical)Tj
6.3723 0 Td
(expenditure)Tj
5.0116 0 Td
(for)Tj
1.3889 0 Td
(essential)Tj
3.583 0 Td
(categories)Tj
4.1896 0 Td
([)Tj
0.83 0.64 0.02 0 k
(9)Tj
0 g
(].)Tj
-20.7211 -1.3039 Td
(Within)Tj
3.0897 0 Td
(an)Tj
1.2019 0 Td
(Italian)Tj
2.7836 0 Td
(local)Tj
2.0693 0 Td
(setting,)Tj
3.1011 0 Td
(Lombardy)Tj
4.3766 0 Td
(Region)Tj
3.0444 0 Td
(\(the)Tj
1.8085 0 Td
(Italian)Tj
2.7836 0 Td
(Region)Tj
3.0444 0 Td
(with)Tj
1.9956 0 Td
(the)Tj
1.4626 0 Td
(highest)Tj
3.0841 0 Td
(preva-)Tj
-35.0416 -1.2983 Td
(lence)Tj
2.2847 0 Td
(for)Tj
1.3833 0 Td
(HIV)Tj
2.0239 0 Td
(infection)Tj
3.7927 0 Td
(and)Tj
1.7291 0 Td
(a)Tj
0.652 0 Td
(significant)Tj
4.388 0 Td
(HIV)Tj
2.0239 0 Td
(incidence)Tj
4.0762 0 Td
(rate)Tj
1.7462 0 Td
([)Tj
0.83 0.64 0.02 0 k
(10)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(11)Tj
0 g
(]\))Tj
3.3675 0 Td
(proposed)Tj
3.9515 0 Td
(some)Tj
2.33 0 Td
(CG)Tj
1.5988 0 Td
(tools)Tj
-35.3478 -1.2983 Td
(for)Tj
1.3832 0 Td
(monitoring)Tj
4.8189 0 Td
(and)Tj
1.7348 0 Td
(controlling)Tj
4.6488 0 Td
(HIV)Tj
2.0183 0 Td
(related)Tj
2.948 0 Td
(expenditure.)Tj
5.2384 0 Td
(Two)Tj
2.0239 0 Td
(main)Tj
2.2847 0 Td
(activities)Tj
3.719 0 Td
(were)Tj
2.1203 0 Td
(imple-)Tj
-32.9383 -1.3039 Td
(mented)Tj
3.2598 0 Td
(in)Tj
1.0374 0 Td
(Lombardy)Tj
4.3767 0 Td
(Region:)Tj
3.2768 0 Td
(i\))Tj
0.8278 0 Td
(direct)Tj
2.5341 0 Td
(delivery)Tj
3.3902 0 Td
(of)Tj
1.0148 0 Td
(drugs)Tj
2.4718 0 Td
(by)Tj
1.1792 0 Td
(hospitals,)Tj
3.9685 0 Td
(providing)Tj
4.1442 0 Td
(HIV+)Tj
2.6022 0 Td
(patients)Tj
-34.0835 -1.2982 Td
(with)Tj
1.9955 0 Td
(ART,)Tj
2.3641 0 Td
(covering)Tj
3.6794 0 Td
(a)Tj
0.6519 0 Td
(time)Tj
2.0296 0 Td
(horizon)Tj
3.3619 0 Td
(of)Tj
1.0148 0 Td
(no)Tj
1.2756 0 Td
(more)Tj
2.3414 0 Td
(than)Tj
2.0296 0 Td
(60)Tj
1.1735 0 Td
(days,)Tj
2.2223 0 Td
(and)Tj
1.7292 0 Td
(ii\))Tj
1.0941 0 Td
(introduction)Tj
5.3121 0 Td
(of)Tj
1.0148 0 Td
(a)Tj
0.652 0 Td
(Clinical)Tj
-33.9418 -1.2983 Td
(Pathway)Tj
3.6113 0 Td
(\(CP\),)Tj
2.347 0 Td
(in)Tj
1.0375 0 Td
(August)Tj
3.0841 0 Td
(2011.)Tj
-8.8837 -1.3039 Td
(Even)Tj
2.2166 0 Td
(if)Tj
0.7767 0 Td
(the)Tj
1.4684 0 Td
(literature)Tj
3.8834 0 Td
(evidence)Tj
3.7134 0 Td
(debates)Tj
3.1918 0 Td
(on)Tj
1.2755 0 Td
(the)Tj
1.4684 0 Td
(correct)Tj
3.0387 0 Td
(definition)Tj
4.1669 0 Td
(of)Tj
1.0148 0 Td
(a)Tj
0.652 0 Td
(CP,)Tj
1.6667 0 Td
(five)Tj
1.6554 0 Td
(criteria)Tj
3.0728 0 Td
(were)Tj
-34.4577 -1.2983 Td
(generally)Tj
3.8324 0 Td
(taken)Tj
2.4207 0 Td
(into)Tj
1.8425 0 Td
(account)Tj
3.3789 0 Td
(for)Tj
1.389 0 Td
(a)Tj
0.652 0 Td
(CP)Tj
1.4456 0 Td
(predisposition)Tj
5.9584 0 Td
(and)Tj
1.7291 0 Td
(implementation:)Tj
6.8655 0 Td
(1\))Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(CP)Tj
1.44 0 Td
(strictly)Tj
-33.4599 -1.2982 Td
(implies)Tj
3.118 0 Td
(a)Tj
0.6577 0 Td
(multidisciplinary)Tj
7.0639 0 Td
(approach;)Tj
4.1782 0 Td
(2\))Tj
1.0318 0 Td
(the)Tj
1.474 0 Td
(CP)Tj
1.44 0 Td
(implementation)Tj
6.6387 0 Td
(aims)Tj
2.1033 0 Td
(at)Tj
0.9524 0 Td
(standardising)Tj
5.6296 0 Td
(phases,)Tj
-34.2876 -1.2983 Td
(procedures)Tj
4.6714 0 Td
(or)Tj
1.0999 0 Td
(episodes)Tj
3.6056 0 Td
(of)Tj
1.0148 0 Td
(healthcare)Tj
4.3313 0 Td
(delivery,)Tj
3.617 0 Td
(within)Tj
2.8119 0 Td
(a)Tj
0.652 0 Td
(specific)Tj
3.1918 0 Td
(target)Tj
2.5115 0 Td
(population)Tj
4.5921 0 Td
([)Tj
0.83 0.64 0.02 0 k
(12)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(13)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(14)Tj
0 g
(];)Tj
4.4277 0 Td
(3\))Tj
-36.527 -1.3039 Td
(the)Tj
1.4683 0 Td
(pathway)Tj
3.5716 0 Td
(translates)Tj
3.9968 0 Td
(evidence)Tj
3.7077 0 Td
(and)Tj
1.7348 0 Td
(guidelines)Tj
4.2746 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4684 0 Td
(different)Tj
3.6566 0 Td
(local)Tj
2.075 0 Td
(settings)Tj
3.2428 0 Td
([)Tj
0.83 0.64 0.02 0 k
(15)Tj
0 g
(];)Tj
2.0806 0 Td
(4\))Tj
1.0318 0 Td
(the)Tj
1.474 0 Td
(CP)Tj
-34.8205 -1.2983 Td
(could)Tj
2.4491 0 Td
(be)Tj
1.1452 0 Td
(synthesise)Tj
4.2462 0 Td
(in)Tj
1.0318 0 Td
(a)Tj
0.652 0 Td
(inventory)Tj
4.4844 0 Td
(of)Tj
1.0091 0 Td
(actions)Tj
3.4526 0 Td
([)Tj
0.83 0.64 0.02 0 k
(16)Tj
0 g
(],)Tj
2.0749 0 Td
(to)Tj
1.0205 0 Td
(be)Tj
1.1452 0 Td
(implemented)Tj
5.5332 0 Td
(and)Tj
1.7291 0 Td
(measured)Tj
4.1045 0 Td
(to)Tj
1.0262 0 Td
(moni-)Tj
-35.104 -1.2983 Td
(tor)Tj
1.3946 0 Td
(the)Tj
1.4683 0 Td
(clinicians)Tj
4.0082 0 Td
(behaviours;)Tj
4.8245 0 Td
(5\))Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(CP)Tj
1.4457 0 Td
(presents)Tj
3.5206 0 Td
(timeframes,)Tj
4.9549 0 Td
(goals)Tj
2.2337 0 Td
(and)Tj
1.7291 0 Td
(outcomes.)Tj
-26.8892 -1.3039 Td
(Thus,)Tj
2.4774 0 Td
(the)Tj
1.4684 0 Td
(studied)Tj
3.1521 0 Td
(HIV)Tj
2.0239 0 Td
(CP)Tj
1.44 0 Td
(was)Tj
1.7008 0 Td
(defined)Tj
3.2258 0 Td
(in)Tj
1.0374 0 Td
(accordance)Tj
4.7339 0 Td
(with)Tj
1.9955 0 Td
(the)Tj
1.4741 0 Td
(above)Tj
2.5455 0 Td
(mentioned)Tj
4.5807 0 Td
(five)Tj
1.6554 0 Td
(crite-)Tj
-34.7071 -1.2982 Td
(ria,)Tj
1.5136 0 Td
(detailed)Tj
3.3732 0 Td
(in)Tj
1.0319 0 Td
(the)Tj
1.474 0 Td
(followings:)Tj
-7.3927 -1.8992 Td
(1.)Tj
1.2018 0 Td
(the)Tj
1.4684 0 Td
(multi-disciplinary)Tj
7.4154 0 Td
(team)Tj
2.194 0 Td
(involved)Tj
3.651 0 Td
(in)Tj
1.0374 0 Td
(the)Tj
1.4684 0 Td
(CP)Tj
1.44 0 Td
(predisposition)Tj
5.964 0 Td
(was)Tj
1.6951 0 Td
(composed)Tj
4.3087 0 Td
(of)Tj
1.0148 0 Td
(a)Tj
0.6519 0 Td
(RHS)Tj
2.0863 0 Td
(dele-)Tj
-34.3954 -1.2983 Td
(gate,)Tj
2.0636 0 Td
(a)Tj
0.652 0 Td
(health)Tj
2.6816 0 Td
(economics)Tj
4.5014 0 Td
(expert,)Tj
2.9423 0 Td
(a)Tj
0.652 0 Td
(hospital)Tj
3.3788 0 Td
(pharmacist,)Tj
4.8983 0 Td
(two)Tj
1.7121 0 Td
(Infectious)Tj
4.2066 0 Td
(Disease)Tj
3.2258 0 Td
(specialists,)Tj
-30.9145 -1.3039 Td
(one)Tj
1.6951 0 Td
(patients')Tj
3.583 0 Td
(association)Tj
4.6318 0 Td
(delegate.)Tj
3.685 0 Td
(All)Tj
1.3946 0 Td
(the)Tj
1.4741 0 Td
(representatives)Tj
6.1964 0 Td
(were)Tj
2.1203 0 Td
(directly)Tj
3.2315 0 Td
(selected)Tj
3.3506 0 Td
(by)Tj
1.1792 0 Td
(the)Tj
1.4683 0 Td
(Head)Tj
-34.0099 -1.2983 Td
(of)Tj
1.0148 0 Td
(Lombardy)Tj
4.3767 0 Td
(Region)Tj
3.0557 0 Td
(Pharmaceutical)Tj
6.4063 0 Td
(Department,)Tj
5.3177 0 Td
(and)Tj
1.7292 0 Td
(consensus)Tj
4.2803 0 Td
(concerning)Tj
4.7508 0 Td
(every)Tj
2.3471 0 Td
(deci-)Tj
-33.2786 -1.2983 Td
(sion)Tj
1.8992 0 Td
(was)Tj
1.7008 0 Td
(achieved)Tj
3.702 0 Td
(with)Tj
1.9956 0 Td
(the)Tj
1.474 0 Td
(majority)Tj
3.6283 0 Td
(of)Tj
1.0148 0 Td
(votes;)Tj
-16.6165 -1.8992 Td
(2.)Tj
1.2018 0 Td
(the)Tj
1.4684 0 Td
(CP)Tj
1.44 0 Td
(was)Tj
1.7007 0 Td
(addressed)Tj
4.1783 0 Td
(to)Tj
1.0261 0 Td
(the)Tj
1.4684 0 Td
(population)Tj
4.592 0 Td
(with)Tj
1.9956 0 Td
(HIV)Tj
2.024 0 Td
(diagnosis.)Tj
4.1839 0 Td
(In)Tj
1.1055 0 Td
(particular:)Tj
/F12 1 Tf
4.3369 0 Td
[()]TJ
/F8 1 Tf
0.8051 0 Td
(first)Tj
1.8085 0 Td
(line)Tj
-32.1334 -1.3039 Td
(patients,)Tj
/F12 1 Tf
3.5887 0 Td
[()12()]TJ
/F8 1 Tf
1.0771 0 Td
(patients)Tj
3.3676 0 Td
(needing)Tj
3.4242 0 Td
(to)Tj
1.0261 0 Td
(switch)Tj
2.778 0 Td
(ART)Tj
2.1373 0 Td
(regimen)Tj
3.5433 0 Td
(for)Tj
1.3833 0 Td
(any)Tj
1.6554 0 Td
(clinical)Tj
3.0784 0 Td
(reason)Tj
2.863 0 Td
(and)Tj
1.7348 0 Td
(for)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 479.8488 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(HIV)Tj
1.8708 0 Td
(Clinical)Tj
3.3662 0 Td
(Pathway)Tj
3.9969 0 Td
(in)Tj
0.9779 0 Td
(Italy)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.4748 0 Td
(DOI:10.137)Tj
5.0387 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.0168)Tj
3.5434 0 Td
(399)Tj
2.6362 0 Td
(December)Tj
4.7622 0 Td
(28,)Tj
1.5874 0 Td
(2016)Tj
36.7515 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
0.496 0 Td
(12)Tj
/F10 1 Tf
-0.025 Tc
-66.402 84.0904 Td
(consulting)Tj
4.0748 0 Td
(fees,)Tj
1.963 0 Td
(support)Tj
3.0969 0 Td
(for)Tj
1.2543 0 Td
(travel)Tj
2.2394 0 Td
(to)Tj
0.9496 0 Td
(conference)Tj
4.089 0 Td
(s,)Tj
-17.667 -1.3748 Td
(participation)Tj
4.7764 0 Td
(in)Tj
0.8858 0 Td
(scientific)Tj
3.4654 0 Td
(board)Tj
2.374 0 Td
(for)Tj
1.2544 0 Td
(MSD,)Tj
2.3102 0 Td
(BMS,)Tj
-15.0662 -1.3749 Td
(Gilead,)Tj
2.7354 0 Td
(Abbott,)Tj
2.8985 0 Td
(Janssen)Tj
3.274 0 Td
(Cilag,)Tj
2.2536 0 Td
(GlaxoSmi)Tj
3.5646 0 Td
(thline,)Tj
-14.7261 -1.3748 Td
(Pfizer,)Tj
2.5086 0 Td
(ViiV)Tj
1.6512 0 Td
(Healthcare)Tj
4.1457 0 Td
(and)Tj
1.5874 0 Td
(AbbVie.)Tj
3.0615 0 Td
(Francesca)Tj
-12.9544 -1.3748 Td
(Scolari,)Tj
2.9764 0 Td
(Elisabetta)Tj
3.7488 0 Td
(Garagiola)Tj
3.7134 0 Td
(and)Tj
1.5874 0 Td
(Elena)Tj
2.204 0 Td
(Ricci)Tj
2.0409 0 Td
(have)Tj
-16.2709 -1.3748 Td
(declared)Tj
3.3519 0 Td
(that)Tj
1.63 0 Td
(no)Tj
1.1622 0 Td
(competing)Tj
4.1599 0 Td
(interests)Tj
3.3874 0 Td
(exist.)Tj
2.1614 0 Td
(This)Tj
-15.8528 -1.3748 Td
(does)Tj
2.0126 0 Td
(not)Tj
1.4173 0 Td
(alter)Tj
1.8213 0 Td
(our)Tj
1.474 0 Td
(adherence)Tj
4.0536 0 Td
(to)Tj
0.9496 0 Td
(PLOS)Tj
2.3315 0 Td
(ONE)Tj
1.8709 0 Td
(policies)Tj
-15.9308 -1.3748 Td
(on)Tj
1.1693 0 Td
(sharing)Tj
2.9834 0 Td
(data)Tj
1.7859 0 Td
(and)Tj
1.5945 0 Td
(material)Tj
ET
endstream
endobj
34 0 obj
<>stream
endstream
endobj
35 0 obj
<>stream
endstream
endobj
36 0 obj
<>stream
endstream
endobj
37 0 obj
<>stream
endstream
endobj
38 0 obj
<>stream
endstream
endobj
39 0 obj
<>stream
endstream
endobj
40 0 obj
<>stream
endstream
endobj
41 0 obj
<>stream
endstream
endobj
42 0 obj
<>stream
endstream
endobj
43 0 obj
<>stream
endstream
endobj
44 0 obj
<>stream
endstream
endobj
45 0 obj
<>stream
endstream
endobj
46 0 obj
<>stream
endstream
endobj
47 0 obj
<>stream
endstream
endobj
48 0 obj
<>stream
endstream
endobj
49 0 obj
<>stream
endstream
endobj
50 0 obj
<>stream
BT
10.4953 74.4667 Td
(s.)Tj
ET
Q
endstream
endobj
51 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 11 0 R/Contents 54 0 R/TrimBox[0 0 612 792]>>
endobj
54 0 obj
[55 0 R 56 0 R 57 0 R]
endobj
55 0 obj
<>stream
q
1 j
1 J
0 w
10 0 0 10 212.0314 707.4141 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(economic)Tj
4.1385 0 Td
(factors,)Tj
3.1294 0 Td
(and)Tj
/F12 1 Tf
1.7292 0 Td
[()12()12()]TJ
/F8 1 Tf
1.3379 0 Td
(subjects)Tj
3.3789 0 Td
(experiencing)Tj
5.3631 0 Td
(a)Tj
0.6576 0 Td
(treatment)Tj
4.1329 0 Td
(switch)Tj
2.7836 0 Td
(due)Tj
1.7008 0 Td
(to)Tj
1.0205 0 Td
(the)Tj
1.474 0 Td
(failure)Tj
2.7779 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
-34.6391 -1.3039 Td
(ongoing)Tj
3.5262 0 Td
(therapeutic)Tj
4.7339 0 Td
(regimen;)Tj
-9.4619 -1.8992 Td
(3.)Tj
1.2018 0 Td
(the)Tj
1.4683 0 Td
(most)Tj
2.2053 0 Td
(recent)Tj
2.7099 0 Td
(National)Tj
3.6907 0 Td
(and)Tj
1.7291 0 Td
(International)Tj
5.4879 0 Td
(HIV)Tj
2.0182 0 Td
(guidelines)Tj
4.2803 0 Td
(were)Tj
2.1203 0 Td
(taken)Tj
2.4208 0 Td
(into)Tj
1.8425 0 Td
(consideration,)Tj
-29.9733 -1.2982 Td
(in)Tj
1.0318 0 Td
(order)Tj
2.4207 0 Td
(to)Tj
1.0262 0 Td
(write)Tj
2.2677 0 Td
(and)Tj
1.7291 0 Td
(update)Tj
2.948 0 Td
(the)Tj
1.4683 0 Td
(CP,)Tj
1.6668 0 Td
(every)Tj
2.3471 0 Td
(12)Tj
1.1735 0 Td
(months;)Tj
-19.281 -1.8992 Td
(4.)Tj
1.2018 0 Td
(the)Tj
1.4683 0 Td
(CP)Tj
1.44 0 Td
(established)Tj
4.5977 0 Td
(the)Tj
1.4684 0 Td
(diagnostic)Tj
4.32 0 Td
(procedures)Tj
4.6771 0 Td
(\(in)Tj
1.372 0 Td
(particular)Tj
4.1102 0 Td
(when)Tj
2.4037 0 Td
(to)Tj
1.0262 0 Td
(provide)Tj
3.2881 0 Td
(the)Tj
1.474 0 Td
(HIV)Tj
2.0183 0 Td
(Geno-)Tj
-33.664 -1.2983 Td
(typic)Tj
2.1769 0 Td
(Resistance)Tj
4.3824 0 Td
(test,)Tj
1.8255 0 Td
(or)Tj
1.0998 0 Td
(CD4+)Tj
2.6759 0 Td
(count\),)Tj
3.0897 0 Td
(the)Tj
1.4684 0 Td
(criteria)Tj
3.0784 0 Td
(to)Tj
1.0261 0 Td
(start)Tj
1.9843 0 Td
(the)Tj
1.4683 0 Td
(treatment,)Tj
4.3597 0 Td
(and)Tj
1.7291 0 Td
(how)Tj
1.9389 0 Td
(to)Tj
1.0261 0 Td
(select)Tj
-33.3295 -1.3039 Td
(it,)Tj
1.0091 0 Td
(for)Tj
1.3833 0 Td
(the)Tj
1.474 0 Td
(target)Tj
2.5115 0 Td
(population.)Tj
4.8132 0 Td
(Furthermore,)Tj
5.6125 0 Td
(the)Tj
1.474 0 Td
(HIV)Tj
2.0183 0 Td
(CP)Tj
1.4456 0 Td
(clearly)Tj
2.8177 0 Td
(stated)Tj
2.5625 0 Td
(that)Tj
1.7801 0 Td
(clinicians)Tj
4.0025 0 Td
(should)Tj
-32.9043 -1.2983 Td
(select)Tj
2.3924 0 Td
(the)Tj
1.4683 0 Td
(less)Tj
1.6158 0 Td
(expensive)Tj
4.1045 0 Td
(pharmacological)Tj
6.8428 0 Td
(treatments,)Tj
4.7225 0 Td
(that)Tj
1.7745 0 Td
(ensure)Tj
2.8799 0 Td
(the)Tj
1.4684 0 Td
(same)Tj
2.2563 0 Td
(clinical)Tj
3.0784 0 Td
(condi-)Tj
-32.6038 -1.2982 Td
(tion,)Tj
2.0636 0 Td
(in)Tj
1.0374 0 Td
(order)Tj
2.4208 0 Td
(to)Tj
1.0261 0 Td
(facilitate)Tj
3.6 0 Td
(the)Tj
1.4684 0 Td
(correct)Tj
3.0387 0 Td
(use)Tj
1.5307 0 Td
(of)Tj
1.0148 0 Td
(available)Tj
3.668 0 Td
(resources,)Tj
4.2122 0 Td
(giving)Tj
2.6873 0 Td
(the)Tj
1.474 0 Td
(additional)Tj
4.2746 0 Td
(possi-)Tj
-33.5166 -1.304 Td
(bility)Tj
2.2563 0 Td
(to)Tj
1.0261 0 Td
(switch)Tj
2.7837 0 Td
(treatment)Tj
4.1328 0 Td
(for)Tj
1.389 0 Td
(economic)Tj
4.1386 0 Td
(reasons)Tj
3.2258 0 Td
(and)Tj
1.7291 0 Td
(not)Tj
1.576 0 Td
(only)Tj
1.9786 0 Td
(for)Tj
1.3833 0 Td
(clinical)Tj
3.0784 0 Td
(factors.)Tj
3.1238 0 Td
(All)Tj
1.4003 0 Td
(these)Tj
-33.2218 -1.2982 Td
(recommendations)Tj
7.5004 0 Td
(were)Tj
2.1203 0 Td
(consistent)Tj
4.2576 0 Td
(with)Tj
1.9956 0 Td
(HIV)Tj
2.0239 0 Td
(evidence)Tj
3.7134 0 Td
(and)Tj
1.7291 0 Td
(guidelines;)Tj
-24.5421 -1.8992 Td
(5.)Tj
1.2018 0 Td
(in)Tj
1.0318 0 Td
(order)Tj
2.4207 0 Td
(to)Tj
1.0262 0 Td
(verify)Tj
2.4831 0 Td
(the)Tj
1.4683 0 Td
(CP)Tj
1.44 0 Td
(adequacy,)Tj
4.1783 0 Td
(Lombardy)Tj
4.3766 0 Td
(Region)Tj
3.0558 0 Td
(should)Tj
2.9196 0 Td
(i\))Tj
0.8221 0 Td
(plan)Tj
1.9672 0 Td
(internal)Tj
3.3619 0 Td
(auditing)Tj
3.5546 0 Td
(activ-)Tj
-34.1062 -1.2983 Td
(ities)Tj
1.8368 0 Td
(in)Tj
1.0318 0 Td
(each)Tj
2.0296 0 Td
(hospital,)Tj
3.6056 0 Td
(in)Tj
1.0375 0 Td
(order)Tj
2.4208 0 Td
(to)Tj
1.0204 0 Td
(verify)Tj
2.4832 0 Td
(the)Tj
1.4683 0 Td
(prescriptive)Tj
4.9153 0 Td
(appropriateness,)Tj
6.7974 0 Td
(ii\))Tj
1.0942 0 Td
(collect)Tj
2.7892 0 Td
(once)Tj
2.1203 0 Td
(a)Tj
-34.6504 -1.3039 Td
(year,)Tj
2.1259 0 Td
(as)Tj
1.0148 0 Td
(regards)Tj
3.1748 0 Td
(the)Tj
1.4683 0 Td
(previous)Tj
3.651 0 Td
(12)Tj
1.1736 0 Td
(months,)Tj
3.5036 0 Td
(the)Tj
1.474 0 Td
(number)Tj
3.4129 0 Td
(of:)Tj
1.2415 0 Td
(new)Tj
1.8766 0 Td
(patients)Tj
3.3675 0 Td
(starting)Tj
3.2655 0 Td
(the)Tj
1.4683 0 Td
(treatment,)Tj
-32.2183 -1.2983 Td
(patients)Tj
3.3675 0 Td
(switching)Tj
4.0592 0 Td
(treatment)Tj
4.1385 0 Td
(for)Tj
1.3833 0 Td
(any)Tj
1.6611 0 Td
(reason,)Tj
3.0898 0 Td
(subjects)Tj
3.3788 0 Td
(experiencing)Tj
5.3632 0 Td
(failure,)Tj
3.0047 0 Td
(patients)Tj
3.3675 0 Td
(treated)Tj
-32.8136 -1.2982 Td
(with)Tj
1.9955 0 Td
(high-cost)Tj
3.9458 0 Td
(drugs,)Tj
2.6986 0 Td
(average)Tj
3.2258 0 Td
(monthly)Tj
3.6227 0 Td
(and)Tj
1.7291 0 Td
(annual)Tj
2.9593 0 Td
(cost)Tj
1.8142 0 Td
(per)Tj
1.5307 0 Td
(Infectious)Tj
4.2066 0 Td
(Disease)Tj
3.2258 0 Td
(Department,)Tj
-30.9541 -1.304 Td
(comparing)Tj
4.5694 0 Td
(and)Tj
1.7348 0 Td
(sharing)Tj
3.1918 0 Td
(this)Tj
1.6724 0 Td
(information)Tj
5.0796 0 Td
(with)Tj
1.9956 0 Td
(all)Tj
1.1452 0 Td
(Regional)Tj
3.736 0 Td
(Hospitals,)Tj
4.201 0 Td
(using)Tj
2.3924 0 Td
(a)Tj
0.652 0 Td
(benchmarking)Tj
-30.3702 -1.2982 Td
(approach;)Tj
4.1725 0 Td
(iii\))Tj
1.3663 0 Td
(verify)Tj
2.4775 0 Td
(every)Tj
2.347 0 Td
(year,)Tj
2.1317 0 Td
(with)Tj
1.9956 0 Td
(specific)Tj
3.1918 0 Td
(performance)Tj
5.3461 0 Td
(indicators,)Tj
4.4503 0 Td
(the)Tj
1.4684 0 Td
(reduction)Tj
4.1158 0 Td
(in)Tj
-33.063 -1.2983 Td
(resources)Tj
3.9854 0 Td
(consumption)Tj
5.5502 0 Td
(and)Tj
1.7292 0 Td
(the)Tj
1.4683 0 Td
(effectiveness)Tj
5.2044 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(HIV)Tj
2.0239 0 Td
(CP)Tj
1.44 0 Td
(implementation.)Tj
-23.8901 -1.8992 Td
(The)Tj
1.7857 0 Td
(introduction)Tj
5.3121 0 Td
(of)Tj
1.0148 0 Td
(this)Tj
1.6724 0 Td
(CP)Tj
1.4457 0 Td
(\(mandatory)Tj
4.9549 0 Td
(since)Tj
2.2394 0 Td
(2011)Tj
2.1259 0 Td
(for)Tj
1.3833 0 Td
(all)Tj
1.1509 0 Td
(the)Tj
1.4683 0 Td
(Lombardy)Tj
4.3767 0 Td
(Region)Tj
3.0557 0 Td
(Hospitals\))Tj
-33.182 -1.3039 Td
(was)Tj
1.695 0 Td
(also)Tj
1.7688 0 Td
(encouraged)Tj
4.8755 0 Td
(as)Tj
1.0148 0 Td
(a)Tj
0.652 0 Td
(strategic)Tj
3.5603 0 Td
(objective)Tj
3.7814 0 Td
(to)Tj
1.0261 0 Td
(be)Tj
1.1509 0 Td
(achieved)Tj
3.702 0 Td
(by)Tj
1.1792 0 Td
(the)Tj
1.474 0 Td
(Hospital)Tj
3.617 0 Td
(General)Tj
3.3846 0 Td
(Managers)Tj
-32.8816 -1.2983 Td
(and)Tj
1.729 0 Td
(consequently)Tj
5.4878 0 Td
(by)Tj
1.1849 0 Td
(the)Tj
1.4683 0 Td
(Head)Tj
2.3698 0 Td
(of)Tj
1.0148 0 Td
(Infectious)Tj
4.2066 0 Td
(Diseases)Tj
3.5886 0 Td
(Units.)Tj
-19.8536 -1.2982 Td
(Moving)Tj
3.3561 0 Td
(on)Tj
1.2756 0 Td
(from)Tj
2.2053 0 Td
(these)Tj
2.2564 0 Td
(premises,)Tj
3.9911 0 Td
(the)Tj
1.4684 0 Td
(primary)Tj
3.4525 0 Td
(objective)Tj
3.7814 0 Td
(of)Tj
1.0148 0 Td
(this)Tj
1.6781 0 Td
(study)Tj
2.3868 0 Td
(was)Tj
1.7008 0 Td
(to)Tj
1.0261 0 Td
(evaluate)Tj
3.4582 0 Td
(the)Tj
-34.2478 -1.304 Td
(impact)Tj
2.9762 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.474 0 Td
(introduction)Tj
5.3121 0 Td
(of)Tj
1.0148 0 Td
(Lombardy)Tj
4.3767 0 Td
(Region)Tj
3.0557 0 Td
(HIV)Tj
2.0183 0 Td
(CP)Tj
1.4456 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.474 0 Td
(target)Tj
2.5115 0 Td
(population,)Tj
4.8132 0 Td
(in)Tj
1.0375 0 Td
(terms)Tj
2.4945 0 Td
(of)Tj
-36.0507 -1.2982 Td
(patients')Tj
3.5828 0 Td
(virological)Tj
4.4107 0 Td
(and)Tj
1.7291 0 Td
(immunological)Tj
6.2986 0 Td
(conditions.)Tj
4.6998 0 Td
(In)Tj
1.1112 0 Td
(particular,)Tj
4.3313 0 Td
(the)Tj
1.474 0 Td
(proportions)Tj
4.9889 0 Td
(of)Tj
1.0148 0 Td
(patients)Tj
-33.6412 -1.2983 Td
(achieving)Tj
4.0307 0 Td
(undetectable)Tj
5.3008 0 Td
(viral)Tj
1.9955 0 Td
(load)Tj
1.9333 0 Td
(\(VL)Tj
/F13 1 Tf
0 Tc
1.7914 0 Td
(<)Tj
/F8 1 Tf
-0.004 Tc
(50)Tj
1.9446 0 Td
(copies/mL\))Tj
4.7452 0 Td
(and)Tj
1.7291 0 Td
(CD4+)Tj
/F14 1 Tf
0 Tc
2.6759 0 Td
()Tj
/F8 1 Tf
-0.004 Tc
0.9921 0 Td
(500)Tj
1.6497 0 Td
(was)Tj
1.6952 0 Td
(investigated)Tj
4.9889 0 Td
(as)Tj
-35.4724 -1.3039 Td
(effectiveness)Tj
5.2042 0 Td
(criteria.)Tj
3.2996 0 Td
(The)Tj
1.7801 0 Td
(secondary)Tj
4.2746 0 Td
(objective)Tj
3.7814 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(study)Tj
2.3925 0 Td
(was)Tj
1.6951 0 Td
(to)Tj
1.0261 0 Td
(evaluate)Tj
3.4639 0 Td
(the)Tj
1.4684 0 Td
(overall)Tj
2.9026 0 Td
(HIV-)Tj
-33.7716 -1.2983 Td
(related)Tj
2.9422 0 Td
(management)Tj
5.4368 0 Td
(costs,)Tj
2.3925 0 Td
(before)Tj
2.7439 0 Td
(and)Tj
1.7291 0 Td
(after)Tj
2.0353 0 Td
(the)Tj
1.4683 0 Td
(CP)Tj
1.4457 0 Td
(implementation,)Tj
6.8598 0 Td
(considering)Tj
4.9322 0 Td
(the)Tj
1.4683 0 Td
(budget)Tj
-33.4541 -1.2982 Td
(holder)Tj
2.8232 0 Td
(\(RHS\))Tj
2.7666 0 Td
(perspective,)Tj
4.9209 0 Td
(consistently)Tj
4.9606 0 Td
(with)Tj
1.9955 0 Td
(the)Tj
1.4741 0 Td
(criteria)Tj
3.0727 0 Td
(previously)Tj
4.354 0 Td
(described,)Tj
4.2746 0 Td
(and)Tj
1.7291 0 Td
(verifying)Tj
3.7644 0 Td
(if)Tj
-36.1357 -1.2983 Td
(the)Tj
1.4682 0 Td
(strategic)Tj
3.5603 0 Td
(goals)Tj
2.2337 0 Td
(defined)Tj
3.2258 0 Td
(by)Tj
1.1849 0 Td
(the)Tj
1.4683 0 Td
(HIV)Tj
2.0239 0 Td
(CP)Tj
1.44 0 Td
(were)Tj
2.1203 0 Td
(achieved)Tj
3.702 0 Td
(by)Tj
1.1849 0 Td
(the)Tj
1.4684 0 Td
(hospitals.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 261.0141 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Materials)Tj
4.5071 0 Td
(and)Tj
1.989 0 Td
(Methods)Tj
/F0 1 Tf
-6.4961 -1.5023 Td
(Study)Tj
2.7543 0 Td
(design)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 225.9779 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(A)Tj
0.9014 0 Td
(multi-centre)Tj
5.2213 0 Td
(observational)Tj
5.5786 0 Td
(cohort)Tj
2.8516 0 Td
(study)Tj
2.3925 0 Td
(was)Tj
1.7007 0 Td
(designed,)Tj
3.9855 0 Td
(composed)Tj
4.3087 0 Td
(of)Tj
1.0147 0 Td
(two)Tj
1.7065 0 Td
(different)Tj
3.6567 0 Td
(phases:)Tj
/F12 1 Tf
3.0727 0 Td
[()]TJ
/F8 1 Tf
-36.3909 -1.2982 Td
(the)Tj
1.4683 0 Td
(first)Tj
1.8085 0 Td
(one)Tj
1.6951 0 Td
(was)Tj
1.7008 0 Td
(related)Tj
2.9423 0 Td
(to)Tj
1.0261 0 Td
(the)Tj
1.4684 0 Td
(situation)Tj
3.7304 0 Td
(before)Tj
2.7382 0 Td
(the)Tj
1.474 0 Td
(implementation)Tj
6.6387 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(CP)Tj
1.44 0 Td
(\(before)Tj
3.0841 0 Td
(2011,)Tj
-33.698 -1.2983 Td
(called)Tj
2.5171 0 Td
(Pre-CP\),)Tj
3.7134 0 Td
(retrospectively,)Tj
6.2872 0 Td
(and)Tj
/F12 1 Tf
1.7291 0 Td
[()12()]TJ
/F8 1 Tf
1.0771 0 Td
(the)Tj
1.4684 0 Td
(second)Tj
3.0104 0 Td
(phase)Tj
2.4831 0 Td
(concerning)Tj
4.7452 0 Td
(the)Tj
1.474 0 Td
(period)Tj
2.8346 0 Td
(after)Tj
2.0353 0 Td
(the)Tj
1.4683 0 Td
(appli-)Tj
-34.8432 -1.3039 Td
(cation)Tj
2.6985 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(CP)Tj
1.44 0 Td
(\(after)Tj
2.3755 0 Td
(2011,)Tj
2.347 0 Td
(called)Tj
2.5228 0 Td
(Post-CP\),)Tj
4.0819 0 Td
(prospectively.)Tj
5.7146 0 Td
(The)Tj
1.7802 0 Td
(randomisation)Tj
6.1114 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(centres)Tj
-34.0382 -1.2983 Td
(was)Tj
1.6951 0 Td
(not)Tj
1.5703 0 Td
(possible,)Tj
3.634 0 Td
(for)Tj
1.3833 0 Td
(ethical)Tj
2.8403 0 Td
(and)Tj
1.7292 0 Td
(legislative)Tj
4.1045 0 Td
(reasons)Tj
3.2201 0 Td
(\(the)Tj
1.8085 0 Td
(implementation)Tj
6.6387 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4627 0 Td
(HIV)Tj
2.0239 0 Td
(CP)Tj
1.44 0 Td
(became)Tj
-34.5654 -1.2982 Td
(mandatory)Tj
4.6147 0 Td
(in)Tj
1.0375 0 Td
(all)Tj
1.1452 0 Td
(the)Tj
1.4683 0 Td
(regional)Tj
3.4809 0 Td
(hospitals)Tj
3.7418 0 Td
(in)Tj
1.0374 0 Td
(2011\).)Tj
2.6873 0 Td
(The)Tj
1.7801 0 Td
(only)Tj
1.9786 0 Td
(possible)Tj
3.4072 0 Td
(study)Tj
2.3924 0 Td
(design)Tj
2.812 0 Td
(was)Tj
1.7007 0 Td
(to)Tj
1.0205 0 Td
(com-)Tj
-34.3046 -1.2983 Td
(pare)Tj
1.9672 0 Td
(the)Tj
1.4683 0 Td
(Infectious)Tj
4.2009 0 Td
(Disease)Tj
3.2315 0 Td
(Departments)Tj
5.4482 0 Td
(performances)Tj
5.7089 0 Td
(considering)Tj
4.9323 0 Td
(the)Tj
1.4683 0 Td
(same)Tj
2.2564 0 Td
(organisations)Tj
-30.682 -1.3039 Td
(and)Tj
1.7291 0 Td
(clinicians,)Tj
4.2292 0 Td
(before)Tj
2.744 0 Td
(and)Tj
1.7291 0 Td
(after)Tj
2.0352 0 Td
(the)Tj
1.4684 0 Td
(CP)Tj
1.4456 0 Td
(implementation.)Tj
-14.1844 -1.2983 Td
(Data)Tj
2.1259 0 Td
(from)Tj
2.2054 0 Td
(6)Tj
0.6973 0 Td
(Lombardy)Tj
4.3767 0 Td
(Region)Tj
3.0557 0 Td
(Hospitals)Tj
3.9798 0 Td
(were)Tj
2.1203 0 Td
(collected.)Tj
3.9628 0 Td
(These)Tj
2.5682 0 Td
(Hospitals)Tj
3.9798 0 Td
(provided)Tj
3.8154 0 Td
(care)Tj
1.8709 0 Td
(to)Tj
-35.9544 -1.2982 Td
(approximately)Tj
5.964 0 Td
(42%)Tj
1.9219 0 Td
(of)Tj
1.0091 0 Td
(HIV+)Tj
2.5909 0 Td
(patients)Tj
3.3618 0 Td
(in)Tj
1.0262 0 Td
(the)Tj
1.4626 0 Td
(Lombardy)Tj
4.371 0 Td
(Region)Tj
3.0444 0 Td
(\(Sacco)Tj
2.8176 0 Td
(Hospital,)Tj
3.8325 0 Td
(Milan;)Tj
2.8289 0 Td
(San)Tj
1.6724 0 Td
(Raf-)Tj
-35.9033 -1.304 Td
(faele)Tj
2.0352 0 Td
(Scientific)Tj
3.9005 0 Td
(Institute,)Tj
3.8097 0 Td
(Milan;)Tj
2.8346 0 Td
(San)Tj
1.6781 0 Td
(Paolo)Tj
2.4718 0 Td
(Hospital,)Tj
3.8438 0 Td
(Milan;)Tj
2.8346 0 Td
(Alessandro)Tj
4.6828 0 Td
(Manzoni)Tj
3.8324 0 Td
(Hospital,)Tj
-31.9235 -1.2982 Td
(Lecco;)Tj
2.7609 0 Td
(Ospedale)Tj
3.9004 0 Td
(di)Tj
1.0148 0 Td
(Circolo)Tj
3.2032 0 Td
(Hospital,)Tj
3.8437 0 Td
(Busto)Tj
2.4945 0 Td
(Arsizio,)Tj
3.3165 0 Td
(and)Tj
1.7291 0 Td
(Ospedale)Tj
3.9005 0 Td
(Civile)Tj
2.5398 0 Td
(Hospital,)Tj
3.8437 0 Td
(Legnano\).)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 479.8488 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(HIV)Tj
1.8708 0 Td
(Clinical)Tj
3.3662 0 Td
(Pathway)Tj
3.9969 0 Td
(in)Tj
0.9779 0 Td
(Italy)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.4748 0 Td
(DOI:10.137)Tj
5.0387 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.0168)Tj
3.5434 0 Td
(399)Tj
2.6362 0 Td
(December)Tj
4.7622 0 Td
(28,)Tj
1.5874 0 Td
(2016)Tj
36.7515 0 Td
(3)Tj
0.7654 0 Td
(/)Tj
ET
endstream
endobj
56 0 obj
<>stream
endstream
endobj
57 0 obj
<>stream
BT
66.402 0 Td
(12)Tj
ET
Q
endstream
endobj
58 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 11 0 R/Annots 60 0 R/Contents 61 0 R/TrimBox[0 0 612 792]>>
endobj
60 0 obj
[62 0 R]
endobj
62 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168399.ref015)>>
endobj
61 0 obj
[63 0 R 64 0 R 65 0 R 66 0 R]
endobj
63 0 obj
<>stream
q
0.83 0.64 0.02 0 k
507.4016 628.3276 m
516.926 628.3276 l
h
f*
0 g
1 j
1 J
0 w
10 0 0 10 211.9748 707.4141 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Inclusion)Tj
3.9911 0 Td
(criteria)Tj
3.0784 0 Td
(were)Tj
2.1203 0 Td
(consistent)Tj
4.2576 0 Td
(with)Tj
1.9956 0 Td
(the)Tj
1.474 0 Td
(target)Tj
2.5058 0 Td
(population)Tj
4.5921 0 Td
(of)Tj
1.0148 0 Td
(HIV)Tj
2.0239 0 Td
(CP:)Tj
1.6668 0 Td
(all)Tj
1.1452 0 Td
(HIV)Tj
2.0239 0 Td
(infected)Tj
-33.0857 -1.3039 Td
(adults,)Tj
2.8402 0 Td
(who)Tj
1.9389 0 Td
(started)Tj
2.931 0 Td
(the)Tj
1.474 0 Td
(first)Tj
1.8029 0 Td
(ART)Tj
2.1373 0 Td
(\(first-line\),)Tj
4.5467 0 Td
(who)Tj
1.9389 0 Td
(switched)Tj
3.736 0 Td
(treatment)Tj
4.1329 0 Td
(\(for)Tj
1.7235 0 Td
(any)Tj
1.6611 0 Td
(clinical)Tj
3.0727 0 Td
(reasons\))Tj
-33.9361 -1.2982 Td
(or)Tj
1.0942 0 Td
(who)Tj
1.9331 0 Td
(changed)Tj
3.566 0 Td
(the)Tj
1.4626 0 Td
(therapeutic)Tj
4.7282 0 Td
(regimen)Tj
3.5376 0 Td
(for)Tj
1.3833 0 Td
(failure,)Tj
2.9934 0 Td
(were)Tj
2.1203 0 Td
(enrolled)Tj
3.5093 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.4683 0 Td
(study)Tj
2.3811 0 Td
(cohort,)Tj
3.0784 0 Td
(between)Tj
-34.2876 -1.2983 Td
(November)Tj
4.4616 0 Td
(2009)Tj
2.1203 0 Td
(and)Tj
1.7348 0 Td
(November)Tj
4.4617 0 Td
(2010)Tj
2.1203 0 Td
(\(Pre-CP)Tj
3.4866 0 Td
(phase\))Tj
2.8233 0 Td
(and)Tj
1.7291 0 Td
(between)Tj
3.532 0 Td
(September)Tj
4.4787 0 Td
(2011)Tj
2.1203 0 Td
(and)Tj
1.7348 0 Td
(Sep-)Tj
-34.8035 -1.2983 Td
(tember)Tj
3.0613 0 Td
(2012)Tj
2.1203 0 Td
(\(Post-CP)Tj
3.8608 0 Td
(phase\).)Tj
-7.8462 -1.3039 Td
(Data)Tj
2.1203 0 Td
(were)Tj
2.1203 0 Td
(collected)Tj
3.7303 0 Td
(at)Tj
0.9525 0 Td
(baseline)Tj
3.4242 0 Td
(and)Tj
1.7234 0 Td
(after)Tj
2.0296 0 Td
(12-month)Tj
4.2236 0 Td
(follow)Tj
2.6929 0 Td
(up,)Tj
1.4854 0 Td
(in)Tj
1.0318 0 Td
(both)Tj
2.0522 0 Td
(phases.)Tj
3.0671 0 Td
(HIV+)Tj
2.5965 0 Td
(patients)Tj
-34.4463 -1.2982 Td
(were)Tj
2.1202 0 Td
(stratified)Tj
3.7588 0 Td
(into)Tj
1.8368 0 Td
(the)Tj
1.474 0 Td
(three)Tj
2.262 0 Td
(categories)Tj
4.1953 0 Td
(defined)Tj
3.2258 0 Td
(by)Tj
1.1792 0 Td
(the)Tj
1.474 0 Td
(Lombardy)Tj
4.3767 0 Td
(Region)Tj
3.0557 0 Td
(CP)Tj
1.44 0 Td
([)Tj
0.83 0.64 0.02 0 k
(15)Tj
0 g
(],)Tj
2.0749 0 Td
(and)Tj
1.7348 0 Td
(consid-)Tj
-34.2082 -1.2983 Td
(ered)Tj
1.9672 0 Td
(as)Tj
1.0148 0 Td
(independent)Tj
5.2724 0 Td
(samples)Tj
3.3845 0 Td
(of)Tj
1.0148 0 Td
(reference)Tj
3.9118 0 Td
(for)Tj
1.389 0 Td
(the)Tj
1.4683 0 Td
(analysis:)Tj
3.5546 0 Td
(\(i\))Tj
1.1679 0 Td
(First-line)Tj
4.6658 0 Td
(patients,)Tj
3.5886 0 Td
(who)Tj
1.9389 0 Td
(started)Tj
-34.3386 -1.3039 Td
(the)Tj
1.4683 0 Td
(first)Tj
1.8085 0 Td
(ART;)Tj
2.3584 0 Td
(\(ii\))Tj
1.4343 0 Td
(Switch)Tj
3.2882 0 Td
(for)Tj
1.3889 0 Td
(toxicity/other)Tj
6.0491 0 Td
(patients,)Tj
3.5943 0 Td
(who)Tj
1.9389 0 Td
(switched)Tj
3.7304 0 Td
(treatment)Tj
4.1386 0 Td
(for)Tj
1.3832 0 Td
(toxicity,)Tj
-32.5811 -1.2983 Td
(comorbidity,)Tj
5.3971 0 Td
(potential)Tj
3.7587 0 Td
(drug)Tj
2.1089 0 Td
(interaction,)Tj
4.8359 0 Td
(simplification)Tj
5.7316 0 Td
(\(in)Tj
1.372 0 Td
(this)Tj
1.6781 0 Td
(category)Tj
3.5943 0 Td
(the)Tj
1.474 0 Td
(reduction)Tj
4.1102 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
-35.0983 -1.2983 Td
(number)Tj
3.4185 0 Td
(of)Tj
1.0148 0 Td
(pills)Tj
1.8538 0 Td
(or)Tj
1.0999 0 Td
(reduction)Tj
4.1159 0 Td
(in)Tj
1.0374 0 Td
(the)Tj
1.4684 0 Td
(treatment)Tj
4.1329 0 Td
(burden)Tj
3.1294 0 Td
(were)Tj
2.1203 0 Td
(considered\),)Tj
5.1647 0 Td
(and)Tj
1.7348 0 Td
(also)Tj
1.7631 0 Td
(for)Tj
1.389 0 Td
(economic)Tj
-33.4429 -1.3039 Td
(reason,)Tj
3.0897 0 Td
(as)Tj
1.0148 0 Td
(specifically)Tj
4.5694 0 Td
(requested)Tj
4.0875 0 Td
(by)Tj
1.1792 0 Td
(the)Tj
1.4684 0 Td
(HIV)Tj
2.0239 0 Td
(CP;)Tj
1.6668 0 Td
(\(iii\))Tj
1.7007 0 Td
(Switch)Tj
3.2882 0 Td
(for)Tj
1.389 0 Td
(failure)Tj
3.1691 0 Td
(patients,)Tj
3.5943 0 Td
(who)Tj
1.9389 0 Td
(changed)Tj
-34.1799 -1.2982 Td
(treatment)Tj
4.1328 0 Td
(because)Tj
3.3222 0 Td
(of)Tj
1.0148 0 Td
(viro-immunological)Tj
8.2488 0 Td
(and/or)Tj
2.9366 0 Td
(clinical)Tj
3.0785 0 Td
(failure.)Tj
-21.5375 -1.2983 Td
(The)Tj
1.7858 0 Td
(main)Tj
2.2903 0 Td
(outcome)Tj
3.7247 0 Td
(measures)Tj
3.9402 0 Td
(were)Tj
2.1259 0 Td
(viro-immunological)Tj
8.2488 0 Td
(status)Tj
2.5002 0 Td
(and)Tj
1.7291 0 Td
(management)Tj
5.4368 0 Td
(costs,)Tj
2.3924 0 Td
(com-)Tj
-35.3704 -1.3039 Td
(pared)Tj
2.4944 0 Td
(by)Tj
1.1792 0 Td
(period)Tj
2.8346 0 Td
(\(pre-)Tj
2.2224 0 Td
(and)Tj
1.7291 0 Td
(post-CP\))Tj
3.8154 0 Td
(and)Tj
1.7348 0 Td
(stratified)Tj
3.7531 0 Td
(by)Tj
1.1848 0 Td
(patients')Tj
3.583 0 Td
(category)Tj
3.5943 0 Td
(\(First)Tj
2.3868 0 Td
(line,)Tj
1.9332 0 Td
(Switch)Tj
2.8913 0 Td
(for)Tj
-35.3364 -1.2983 Td
(toxicity/other,)Tj
5.8846 0 Td
(Switch)Tj
2.897 0 Td
(for)Tj
1.3833 0 Td
(failure\).)Tj
0.005 Tc
-8.9687 -1.2982 Td
(The)Tj
1.8141 0 Td
(study)Tj
2.4321 0 Td
(was)Tj
1.7235 0 Td
(approved)Tj
4.0478 0 Td
(by)Tj
1.2019 0 Td
(the)Tj
1.491 0 Td
(Hospitals)Tj
4.0649 0 Td
(Ethics)Tj
2.7212 0 Td
(Committees:)Tj
5.4255 0 Td
(the)Tj
1.4967 0 Td
(study)Tj
2.4321 0 Td
(have)Tj
2.0976 0 Td
(been)Tj
-32.1446 -1.2983 Td
(approved)Tj
4.0421 0 Td
(by)Tj
1.2019 0 Td
(the)Tj
1.4967 0 Td
(Ethic)Tj
2.3527 0 Td
(Committee)Tj
4.8189 0 Td
(of)Tj
1.0318 0 Td
(A.O.)Tj
2.5398 0 Td
(Ospedale)Tj
3.9685 0 Td
(Lecco\(Coordinati)Tj
7.5968 0 Td
(ng)Tj
1.2472 0 Td
(Center\))Tj
3.3562 0 Td
(with)Tj
2.0296 0 Td
(the)Tj
-35.6822 -1.3039 Td
(following)Tj
4.0535 0 Td
(approval)Tj
3.7643 0 Td
(number:)Tj
3.7021 0 Td
(Protocollo)Tj
4.8755 0 Td
(n.)Tj
1.0035 0 Td
(0016492/12)Tj
4.9152 0 Td
(U)Tj
0.9581 0 Td
(01.02.11)Tj
3.5887 0 Td
(18/04/2012)Tj
5.1703 0 Td
(and)Tj
1.7462 0 Td
(informed)Tj
-33.7774 -1.2983 Td
(consent)Tj
3.3902 0 Td
(forms)Tj
2.6135 0 Td
(were)Tj
2.16 0 Td
(required)Tj
3.7077 0 Td
(for)Tj
1.4173 0 Td
(all)Tj
1.1735 0 Td
(the)Tj
1.4967 0 Td
(patients)Tj
3.4356 0 Td
(enrolled.)Tj
3.821 0 Td
(The)Tj
1.8085 0 Td
(patients)Tj
3.4413 0 Td
(provided)Tj
3.8891 0 Td
(their)Tj
2.1543 0 Td
(written)Tj
-34.5087 -1.2983 Td
(informed)Tj
4.0421 0 Td
(consent)Tj
3.3959 0 Td
(to)Tj
1.0431 0 Td
(participate)Tj
4.5695 0 Td
(in)Tj
1.0544 0 Td
(this)Tj
1.7065 0 Td
(study)Tj
2.4378 0 Td
(and)Tj
1.7574 0 Td
(the)Tj
1.4967 0 Td
(Ethics)Tj
2.7213 0 Td
(Committees)Tj
5.1873 0 Td
(approved)Tj
4.0479 0 Td
(this)Tj
1.7121 0 Td
(con-)Tj
-35.172 -1.3039 Td
(sent)Tj
1.8878 0 Td
(procedure.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 392.7118 cm
BT
/F0 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Data)Tj
2.3102 0 Td
(collection)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 375.7039 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(The)Tj
1.7801 0 Td
(Case)Tj
2.1033 0 Td
(Report)Tj
2.9593 0 Td
(Forms)Tj
2.8063 0 Td
(used)Tj
2.058 0 Td
(for)Tj
1.3889 0 Td
(data)Tj
1.9106 0 Td
(collection)Tj
4.1102 0 Td
(included)Tj
3.7133 0 Td
(patients')Tj
3.583 0 Td
(demographic)Tj
5.5049 0 Td
(information,)Tj
-31.9179 -1.2982 Td
(immunological)Tj
6.2985 0 Td
(and)Tj
1.7291 0 Td
(virological)Tj
4.4107 0 Td
(status,)Tj
2.7269 0 Td
(and)Tj
1.7291 0 Td
(reasons)Tj
3.2258 0 Td
(for)Tj
1.3833 0 Td
(treatment)Tj
4.1386 0 Td
(modification.)Tj
-24.4458 -1.3039 Td
(Data)Tj
2.1259 0 Td
(related)Tj
2.9424 0 Td
(to)Tj
1.0261 0 Td
(the)Tj
1.4683 0 Td
(economic)Tj
4.1386 0 Td
(consumption)Tj
5.5502 0 Td
(of)Tj
1.0148 0 Td
(resources)Tj
3.9855 0 Td
(for)Tj
1.389 0 Td
(the)Tj
1.4683 0 Td
(treatment)Tj
4.1386 0 Td
(and)Tj
1.7291 0 Td
(care)Tj
1.8708 0 Td
(of)Tj
1.0148 0 Td
(HIV)Tj
-35.0586 -1.2983 Td
(disease)Tj
3.016 0 Td
(such)Tj
2.0579 0 Td
(as)Tj
1.0148 0 Td
(drugs,)Tj
2.6986 0 Td
(hospital)Tj
3.3789 0 Td
(admissions)Tj
4.6771 0 Td
(and)Tj
1.7291 0 Td
(laboratory)Tj
4.3484 0 Td
(tests)Tj
1.9615 0 Td
(were)Tj
2.126 0 Td
(also)Tj
1.7688 0 Td
(collected,)Tj
3.9628 0 Td
(using)Tj
2.3924 0 Td
(an)Tj
1.2019 0 Td
(in-)Tj
-36.3342 -1.2983 Td
(depth)Tj
2.5114 0 Td
(analysis)Tj
3.3279 0 Td
(of)Tj
1.0148 0 Td
(administrative)Tj
5.9924 0 Td
(data)Tj
1.9162 0 Td
(\(i.e.)Tj
1.7008 0 Td
(clinical)Tj
3.0727 0 Td
(or)Tj
1.0998 0 Td
(outpatient)Tj
4.3427 0 Td
(records)Tj
3.2031 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(Hospital\).)Tj
4.1839 0 Td
(With)Tj
-34.8489 -1.3039 Td
(regard)Tj
2.8119 0 Td
(to)Tj
1.0261 0 Td
(economic)Tj
4.1386 0 Td
(data,)Tj
2.1373 0 Td
(reimbursement)Tj
6.3836 0 Td
(tariffs)Tj
2.5285 0 Td
(and)Tj
1.7291 0 Td
(prices)Tj
2.5852 0 Td
(were)Tj
2.1203 0 Td
(reported)Tj
3.6623 0 Td
(in)Tj
1.0375 0 Td
(euros,)Tj
3.4186 0 Td
(consider-)Tj
-33.579 -1.2982 Td
(ing)Tj
1.5023 0 Td
(the)Tj
1.4683 0 Td
(2014)Tj
2.1203 0 Td
(inflation-rate)Tj
5.5049 0 Td
(and)Tj
1.7291 0 Td
(values,)Tj
2.8913 0 Td
(using)Tj
2.3925 0 Td
(the)Tj
1.4683 0 Td
(Consumer)Tj
4.439 0 Td
(Price)Tj
2.2677 0 Td
(Index)Tj
2.5228 0 Td
(for)Tj
1.389 0 Td
(healthcare)Tj
4.3257 0 Td
(expendi-)Tj
-34.0212 -1.2983 Td
(ture)Tj
1.8425 0 Td
(where)Tj
2.6475 0 Td
(necessary,)Tj
4.2463 0 Td
(and)Tj
1.7291 0 Td
(making)Tj
3.2541 0 Td
(economic)Tj
4.1386 0 Td
(measures)Tj
3.9401 0 Td
(directly)Tj
3.2315 0 Td
(comparable,)Tj
5.1307 0 Td
(even)Tj
2.0693 0 Td
(considering)Tj
-32.2297 -1.3039 Td
(two)Tj
1.7064 0 Td
(different)Tj
3.6567 0 Td
(historical)Tj
3.9231 0 Td
(periods.)Tj
3.4186 0 Td
(The)Tj
1.7858 0 Td
(clinical)Tj
3.0727 0 Td
(and)Tj
1.7348 0 Td
(economic)Tj
4.1386 0 Td
(data)Tj
1.9105 0 Td
(were)Tj
2.126 0 Td
(recorded)Tj
3.7927 0 Td
(at)Tj
0.9524 0 Td
(baseline,)Tj
3.6567 0 Td
(and)Tj
-35.875 -1.2983 Td
(then)Tj
2.0182 0 Td
(for)Tj
1.3833 0 Td
(the)Tj
1.474 0 Td
(following)Tj
3.9742 0 Td
(6)Tj
0.6973 0 Td
(months,)Tj
3.5092 0 Td
(both)Tj
2.058 0 Td
(retrospectively)Tj
6.0604 0 Td
(in)Tj
1.0375 0 Td
(Pre-CP)Tj
3.1464 0 Td
(and)Tj
1.7292 0 Td
(prospectively)Tj
5.4878 0 Td
(in)Tj
1.0375 0 Td
(Post-CP)Tj
-33.613 -1.2983 Td
(phase,)Tj
2.7099 0 Td
(for)Tj
1.3833 0 Td
(each)Tj
2.0295 0 Td
(patient.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 203.9811 cm
BT
/F0 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Statistical)Tj
4.4504 0 Td
(methods)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 186.9732 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Categorical)Tj
4.7508 0 Td
(variables)Tj
3.719 0 Td
(were)Tj
2.126 0 Td
(described)Tj
4.0478 0 Td
(by)Tj
1.1849 0 Td
(frequency)Tj
4.1839 0 Td
(\(%\))Tj
1.6611 0 Td
(and)Tj
1.7291 0 Td
(compared)Tj
4.2463 0 Td
(using)Tj
2.3868 0 Td
(the)Tj
1.4683 0 Td
(heterogeneity)Tj
-31.504 -1.2982 Td
(Chi-Square)Tj
4.7678 0 Td
(test)Tj
1.5987 0 Td
(or)Tj
1.0999 0 Td
(the)Tj
1.4683 0 Td
(Mantel-Haenszel)Tj
7.0299 0 Td
(Chi-Square)Tj
4.7678 0 Td
(test,)Tj
1.8312 0 Td
(as)Tj
1.0148 0 Td
(appropriate;)Tj
5.1023 0 Td
(the)Tj
1.4684 0 Td
(Cochrane-Mantel-)Tj
-30.1491 -1.2983 Td
(Hanszel)Tj
3.4128 0 Td
(test)Tj
1.5988 0 Td
(was)Tj
1.7007 0 Td
(used)Tj
2.058 0 Td
(to)Tj
1.0261 0 Td
(control)Tj
3.1238 0 Td
(for)Tj
1.3833 0 Td
(potential)Tj
3.7644 0 Td
(confounders.)Tj
5.4765 0 Td
(Normally)Tj
4.0365 0 Td
(distributed)Tj
4.5977 0 Td
(continuous)Tj
-32.1786 -1.2982 Td
(variables)Tj
3.719 0 Td
(were)Tj
2.1203 0 Td
(described)Tj
4.0535 0 Td
(by)Tj
1.1792 0 Td
(means)Tj
2.8063 0 Td
(\()Tj
/F15 1 Tf
[()]TJ
/F8 1 Tf
(standard)Tj
4.6318 0 Td
(error,)Tj
2.4944 0 Td
(SE\))Tj
1.6044 0 Td
(and)Tj
1.7292 0 Td
(compared)Tj
4.2462 0 Td
(using)Tj
2.3868 0 Td
(the)Tj
1.4683 0 Td
(analysis)Tj
3.3279 0 Td
(of)Tj
-35.7673 -1.304 Td
(variance;)Tj
3.7984 0 Td
(a)Tj
0.6576 0 Td
(general)Tj
3.1294 0 Td
(linear)Tj
2.5115 0 Td
(model)Tj
2.7439 0 Td
(was)Tj
1.7008 0 Td
(applied)Tj
3.1521 0 Td
(when)Tj
2.4038 0 Td
(to)Tj
1.0261 0 Td
(adjust)Tj
2.6249 0 Td
(for)Tj
1.3889 0 Td
(potential)Tj
3.7587 0 Td
(confounding)Tj
5.3802 0 Td
(vari-)Tj
-34.2763 -1.2982 Td
(ables.)Tj
2.4151 0 Td
(As)Tj
1.2642 0 Td
(they)Tj
1.9275 0 Td
(were)Tj
2.1203 0 Td
(right-skewed,)Tj
5.641 0 Td
(costs)Tj
2.1713 0 Td
(were)Tj
2.1203 0 Td
(described)Tj
4.0535 0 Td
(both)Tj
2.0636 0 Td
(by)Tj
1.1792 0 Td
(medians)Tj
3.6 0 Td
(\(interquartile)Tj
5.5445 0 Td
(range,)Tj
-34.1005 -1.2983 Td
(IQR\))Tj
2.262 0 Td
(and)Tj
1.7291 0 Td
(means)Tj
2.8063 0 Td
(\()Tj
/F15 1 Tf
[()]TJ
/F8 1 Tf
1.1282 0 Td
(SE\),)Tj
1.8255 0 Td
(and)Tj
1.7291 0 Td
(compared)Tj
4.2406 0 Td
(using)Tj
2.3868 0 Td
(the)Tj
1.4683 0 Td
(Wilcoxon-Mann-Whitney)Tj
10.7546 0 Td
(test)Tj
1.5987 0 Td
(and)Tj
1.7291 0 Td
(the)Tj
1.4684 0 Td
(analy-)Tj
-35.1267 -1.3039 Td
(sis)Tj
1.2075 0 Td
(of)Tj
1.0148 0 Td
(variance.)Tj
3.8041 0 Td
(If)Tj
0.8447 0 Td
(results)Tj
2.8119 0 Td
(of)Tj
1.0148 0 Td
(these)Tj
2.2507 0 Td
(analyses)Tj
3.4866 0 Td
(were)Tj
2.1203 0 Td
(inconsistent,)Tj
5.3008 0 Td
(the)Tj
1.4683 0 Td
(non-parametric)Tj
6.531 0 Td
(test,)Tj
1.8312 0 Td
(more)Tj
-33.6867 -1.2983 Td
(conservative,)Tj
5.4084 0 Td
(prevailed.)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 479.8488 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(HIV)Tj
1.8708 0 Td
(Clinical)Tj
3.3662 0 Td
(Pathway)Tj
3.9969 0 Td
(in)Tj
0.9779 0 Td
(Italy)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.4748 0 Td
(DOI:10.137)Tj
5.0387 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.0168)Tj
3.5434 0 Td
(399)Tj
2.6362 0 Td
(December)Tj
4.7622 0 Td
(28,)Tj
1.5874 0 Td
(2016)Tj
36.7515 0 Td
(4)Tj
0.7654 0 Td
(/)Tj
ET
endstream
endobj
64 0 obj
<>stream
endstream
endobj
65 0 obj
<>stream
endstream
endobj
66 0 obj
<>stream
BT
66.402 0 Td
(12)Tj
ET
Q
endstream
endobj
67 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 11 0 R/Annots 68 0 R/Contents 69 0 R/TrimBox[0 0 612 792]>>
endobj
68 0 obj
[70 0 R 71 0 R 72 0 R 73 0 R 74 0 R 75 0 R 76 0 R]
endobj
70 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168399.ref011)>>
endobj
71 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168399.t001)>>
endobj
72 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168399.t002)>>
endobj
73 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168399.s001)>>
endobj
74 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168399.s004)>>
endobj
75 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168399.ref017)>>
endobj
76 0 obj
<>/Border[0 0 0]/Dest(Rpone.0168399.t003)>>
endobj
69 0 obj
[77 0 R 78 0 R 79 0 R 80 0 R 81 0 R 82 0 R 83 0 R 84 0 R 85 0 R 86 0 R 87 0 R]
endobj
77 0 obj
<>stream
q
0.83 0.64 0.02 0 k
414.1984 580.1386 m
423.7228 580.1386 l
h
f*
368.7307 541.1339 m
397.9276 541.1339 l
h
f*
446.5134 528.0945 m
475.7102 528.0945 l
h
f*
508.9323 528.0945 m
518.4567 528.0945 l
h
f*
523.6157 528.0945 m
533.1969 528.0945 l
h
f*
344.4661 411.137 m
353.9906 411.137 l
h
f*
334.0346 159.9307 m
363.2315 159.9307 l
h
f*
0 g
1 j
1 J
0 w
10 0 0 10 211.9748 707.4141 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Effectiveness)Tj
5.3517 0 Td
(was)Tj
1.7008 0 Td
(evaluated)Tj
3.9912 0 Td
(at)Tj
0.9524 0 Td
(12-month)Tj
4.2179 0 Td
(visit)Tj
1.8709 0 Td
(\(snapshot)Tj
4.1159 0 Td
(analysis\))Tj
3.668 0 Td
(according)Tj
4.1839 0 Td
(to)Tj
1.0261 0 Td
(intention)Tj
3.9288 0 Td
(to)Tj
-36.2038 -1.3039 Td
(treat:)Tj
2.2676 0 Td
(patients)Tj
3.3676 0 Td
(were)Tj
2.1259 0 Td
(considered)Tj
4.5978 0 Td
(as)Tj
1.0148 0 Td
(first)Tj
1.8085 0 Td
(line,)Tj
1.9276 0 Td
(switch)Tj
2.7836 0 Td
(for)Tj
1.3889 0 Td
(toxicity/other,)Tj
5.8847 0 Td
(switch)Tj
2.7779 0 Td
(for)Tj
1.389 0 Td
(failure,)Tj
2.999 0 Td
(even)Tj
2.075 0 Td
(if)Tj
-36.4079 -1.2982 Td
(during)Tj
2.9253 0 Td
(the)Tj
1.4683 0 Td
(study)Tj
2.3924 0 Td
(period)Tj
2.8347 0 Td
(they)Tj
1.9218 0 Td
(changed)Tj
3.5717 0 Td
(one)Tj
1.7007 0 Td
(or)Tj
1.0942 0 Td
(more)Tj
2.3414 0 Td
(treatments.)Tj
-19.0543 -1.2983 Td
(All)Tj
1.4003 0 Td
(statistical)Tj
3.9061 0 Td
(analyses)Tj
3.4866 0 Td
(were)Tj
2.1203 0 Td
(performed)Tj
4.4673 0 Td
(using)Tj
2.3925 0 Td
(the)Tj
1.4683 0 Td
(statistical)Tj
3.9061 0 Td
(software)Tj
3.5887 0 Td
(SAS/STAT)Tj
4.5694 0 Td
(9.2)Tj
1.3946 0 Td
(\(SAS)Tj
-33.8964 -1.2983 Td
(Institute)Tj
3.5829 0 Td
(Inc.,)Tj
1.9842 0 Td
(Cary,)Tj
2.3641 0 Td
(NC,)Tj
1.8482 0 Td
(USA\).)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 629.1779 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Results)Tj
/F0 1 Tf
0 -1.4976 Td
(Study)Tj
2.7543 0 Td
(sample)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 594.1984 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(The)Tj
1.7801 0 Td
(total)Tj
2.0069 0 Td
(numbers)Tj
3.7757 0 Td
(of)Tj
1.0148 0 Td
(patients)Tj
3.3676 0 Td
(on)Tj
1.2756 0 Td
(ART,)Tj
2.364 0 Td
(taken)Tj
2.4208 0 Td
(in)Tj
1.0375 0 Td
(charge)Tj
2.863 0 Td
(by)Tj
1.1792 0 Td
(the)Tj
1.474 0 Td
(6)Tj
0.6916 0 Td
(participating)Tj
5.3291 0 Td
(hospitals,)Tj
3.9685 0 Td
(were)Tj
-34.5484 -1.2982 Td
(10,079)Tj
2.8232 0 Td
(in)Tj
1.0318 0 Td
(Pre-CP)Tj
3.1521 0 Td
(phase)Tj
2.4832 0 Td
(and)Tj
1.7291 0 Td
(11,143)Tj
2.8233 0 Td
(in)Tj
1.0375 0 Td
(Post-CP)Tj
3.5149 0 Td
(phase)Tj
2.4831 0 Td
([)Tj
0.83 0.64 0.02 0 k
(11)Tj
0 g
(].)Tj
-19.882 -1.3039 Td
(Patients)Tj
3.4129 0 Td
(meeting)Tj
3.4639 0 Td
(the)Tj
1.4683 0 Td
(inclusion)Tj
3.9175 0 Td
(criteria,)Tj
3.3051 0 Td
(and)Tj
1.7292 0 Td
(stratified)Tj
3.753 0 Td
(for)Tj
1.389 0 Td
(the)Tj
1.4683 0 Td
(three)Tj
2.2677 0 Td
(categories)Tj
4.1896 0 Td
(of)Tj
1.0148 0 Td
(interest,)Tj
-32.5755 -1.2983 Td
(were)Tj
2.1203 0 Td
(1,284)Tj
2.347 0 Td
(in)Tj
1.0375 0 Td
(Pre-CP)Tj
3.1464 0 Td
(phase)Tj
2.4832 0 Td
(and)Tj
1.7291 0 Td
(1,135)Tj
2.3471 0 Td
(in)Tj
1.0374 0 Td
(the)Tj
1.4684 0 Td
(Post-CP)Tj
3.5206 0 Td
(phase.)Tj
-20.0408 -1.2983 Td
(Patients')Tj
3.6283 0 Td
(characteristics)Tj
5.9017 0 Td
(are)Tj
1.4513 0 Td
(reported)Tj
3.6624 0 Td
(in)Tj
0.83 0.64 0.02 0 k
1.0318 0 Td
(Table)Tj
2.4434 0 Td
(1)Tj
0 g
(.)Tj
0.9184 0 Td
(Most)Tj
2.2791 0 Td
(patients)Tj
3.3675 0 Td
(switched)Tj
3.736 0 Td
(ART)Tj
2.1374 0 Td
(for)Tj
1.3832 0 Td
(toxicity)Tj
3.2032 0 Td
(or)Tj
-36.3399 -1.3039 Td
(other)Tj
2.347 0 Td
(reasons:)Tj
3.4526 0 Td
(the)Tj
1.4683 0 Td
(reasons)Tj
3.2258 0 Td
(for)Tj
1.389 0 Td
(treatment)Tj
4.1329 0 Td
(switch)Tj
2.7836 0 Td
(are)Tj
1.4457 0 Td
(detailed)Tj
3.3675 0 Td
(in)Tj
0.83 0.64 0.02 0 k
1.0375 0 Td
(Table)Tj
2.4434 0 Td
(2)Tj
0 g
0.6917 0 Td
(\(and)Tj
2.0749 0 Td
(in)Tj
0.83 0.64 0.02 0 k
1.0318 0 Td
(S1)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(S4)Tj
0 g
2.6419 0 Td
(Tables\).)Tj
-33.5336 -1.2982 Td
(Main)Tj
2.3584 0 Td
(reasons)Tj
3.2314 0 Td
(were)Tj
2.1203 0 Td
(toxicity)Tj
3.2032 0 Td
(\(49.1%)Tj
/F12 1 Tf
2.965 0 Td
[()2()]TJ
/F8 1 Tf
0.9864 0 Td
(49.8%\),)Tj
3.1918 0 Td
(reduction)Tj
4.1159 0 Td
(of)Tj
1.0148 0 Td
(number)Tj
3.4186 0 Td
(of)Tj
1.0148 0 Td
(pills)Tj
1.8595 0 Td
(\(26.3%)Tj
/F12 1 Tf
2.9707 0 Td
[()2()]TJ
/F8 1 Tf
0.9808 0 Td
(23.6%\))Tj
-33.4316 -1.2983 Td
(and)Tj
1.7291 0 Td
(adherence)Tj
4.3256 0 Td
(\(7.4%)Tj
/F12 1 Tf
2.4888 0 Td
[()2()]TJ
/F8 1 Tf
0.9865 0 Td
(7.2%\).)Tj
2.7212 0 Td
(The)Tj
1.7802 0 Td
(category)Tj
3.5999 0 Td
(of)Tj
1.0148 0 Td
(switch)Tj
2.778 0 Td
(called)Tj
2.5228 0 Td
(CP)Tj
1.8368 0 Td
(indication)Tj
4.6998 0 Td
(was)Tj
1.6951 0 Td
(an)Tj
1.2076 0 Td
(economic)Tj
-33.3862 -1.2983 Td
(reason)Tj
2.8629 0 Td
(for)Tj
1.389 0 Td
(treatment)Tj
4.1329 0 Td
(change,)Tj
3.2711 0 Td
(required)Tj
3.6397 0 Td
(for)Tj
1.3833 0 Td
(chose)Tj
2.4605 0 Td
(the)Tj
1.474 0 Td
(less)Tj
1.61 0 Td
(costly)Tj
2.5115 0 Td
(drugs)Tj
2.4718 0 Td
(regimen,)Tj
3.7644 0 Td
(to)Tj
1.0261 0 Td
(be)Tj
1.1509 0 Td
(considered)Tj
-33.1481 -1.3039 Td
(only)Tj
1.9729 0 Td
(in)Tj
1.0374 0 Td
(the)Tj
1.4684 0 Td
(Post-CP)Tj
3.5206 0 Td
(Scenario,)Tj
3.8947 0 Td
(because)Tj
3.3222 0 Td
(not)Tj
1.5704 0 Td
(previously)Tj
4.354 0 Td
(present:)Tj
3.3845 0 Td
(it)Tj
0.7881 0 Td
(represented)Tj
4.9096 0 Td
(only)Tj
1.9785 0 Td
(the)Tj
1.4684 0 Td
(3.8%)Tj
2.1543 0 Td
(of)Tj
-35.824 -1.2983 Td
(the)Tj
1.4683 0 Td
(switches)Tj
3.5659 0 Td
(total)Tj
2.0013 0 Td
(amount.)Tj
-5.8393 -1.2982 Td
(In)Tj
1.1111 0 Td
(both)Tj
2.058 0 Td
(samples,)Tj
3.6113 0 Td
(patients)Tj
3.3675 0 Td
(were)Tj
2.1203 0 Td
(predominantly)Tj
6.1852 0 Td
(males.)Tj
2.7326 0 Td
(Study)Tj
2.5001 0 Td
(population)Tj
4.5921 0 Td
(was)Tj
1.7008 0 Td
(46.4)Tj
/F15 1 Tf
1.8708 0 Td
[()]TJ
/F8 1 Tf
(0.2)Tj
1.9673 0 Td
(years)Tj
-35.0133 -1.3039 Td
(old,)Tj
1.7234 0 Td
(the)Tj
1.4683 0 Td
(mean)Tj
2.4492 0 Td
(age)Tj
1.542 0 Td
(was)Tj
1.7008 0 Td
(46.3)Tj
/F15 1 Tf
1.8708 0 Td
[()]TJ
/F8 1 Tf
(0.3)Tj
1.9673 0 Td
(years)Tj
2.262 0 Td
(old)Tj
1.5023 0 Td
(in)Tj
1.0375 0 Td
(Pre-CP)Tj
3.1465 0 Td
(Phase)Tj
2.5228 0 Td
(and)Tj
1.7291 0 Td
(46.5)Tj
/F15 1 Tf
1.8709 0 Td
[()]TJ
/F8 1 Tf
(0.3)Tj
1.9672 0 Td
(years)Tj
2.2677 0 Td
(old)Tj
1.4967 0 Td
(in)Tj
1.0374 0 Td
(the)Tj
1.4684 0 Td
(Post-)Tj
-35.0303 -1.2983 Td
(CP)Tj
1.4399 0 Td
(Phase;)Tj
2.7496 0 Td
(these)Tj
2.2564 0 Td
(data)Tj
1.9162 0 Td
(were)Tj
2.1203 0 Td
(consistent)Tj
4.2576 0 Td
(with)Tj
1.9956 0 Td
(the)Tj
1.4683 0 Td
(general)Tj
3.1351 0 Td
(HIV+)Tj
2.6022 0 Td
(population)Tj
4.5921 0 Td
(taken)Tj
2.4208 0 Td
(in)Tj
1.0318 0 Td
(charge)Tj
2.8686 0 Td
(by)Tj
1.1792 0 Td
(the)Tj
-36.0337 -1.2983 Td
(Italian)Tj
2.7892 0 Td
(National)Tj
3.6907 0 Td
(Healthcare)Tj
4.5694 0 Td
(Service)Tj
3.0558 0 Td
([)Tj
0.83 0.64 0.02 0 k
(17)Tj
0 g
(].)Tj
-12.9089 -1.3039 Td
(The)Tj
1.7858 0 Td
(main)Tj
2.2904 0 Td
(risk)Tj
1.7121 0 Td
(factors)Tj
2.9026 0 Td
(for)Tj
1.389 0 Td
(HIV)Tj
2.0239 0 Td
(acquisition)Tj
4.6261 0 Td
(were)Tj
2.1203 0 Td
(heterosexual)Tj
5.2328 0 Td
(intercourse)Tj
4.7395 0 Td
(for)Tj
1.3889 0 Td
(women)Tj
3.2032 0 Td
(and)Tj
-34.6108 -1.2982 Td
(homosexual)Tj
5.0399 0 Td
(intercourse)Tj
4.7395 0 Td
(for)Tj
1.389 0 Td
(men.)Tj
-9.9722 -1.2983 Td
(On)Tj
1.5137 0 Td
(average,)Tj
3.4469 0 Td
(at)Tj
0.9524 0 Td
(the)Tj
1.4683 0 Td
(baseline,)Tj
3.651 0 Td
(the)Tj
1.4684 0 Td
(study)Tj
2.3867 0 Td
(population)Tj
4.5865 0 Td
(have)Tj
2.0579 0 Td
(been)Tj
2.1203 0 Td
(receiving)Tj
3.8608 0 Td
(anti-retroviral)Tj
5.8563 0 Td
(therapy)Tj
-34.5654 -1.2983 Td
(for)Tj
1.3832 0 Td
(approximately)Tj
5.9754 0 Td
(8.2)Tj
/F15 1 Tf
1.4003 0 Td
[()]TJ
/F8 1 Tf
(0.1)Tj
1.9616 0 Td
(years)Tj
2.2677 0 Td
(\(8.1)Tj
/F15 1 Tf
1.7348 0 Td
[()]TJ
/F8 1 Tf
(0.2)Tj
1.9672 0 Td
(years)Tj
2.2621 0 Td
(in)Tj
1.0374 0 Td
(Pre-CP)Tj
3.1465 0 Td
(Phase)Tj
/F12 1 Tf
2.5285 0 Td
[()2()]TJ
/F8 1 Tf
0.9808 0 Td
(8.2)Tj
/F15 1 Tf
1.3946 0 Td
[()]TJ
/F8 1 Tf
(0.2)Tj
1.9672 0 Td
(years)Tj
2.2677 0 Td
(in)Tj
1.0318 0 Td
(Post-CP)Tj
-33.3068 -1.3039 Td
(Phase\).)Tj
1.1962 -1.2983 Td
(With)Tj
2.279 0 Td
(regard)Tj
2.8176 0 Td
(to)Tj
1.0205 0 Td
(ART,)Tj
2.3641 0 Td
(proportions)Tj
4.9946 0 Td
(of)Tj
1.0148 0 Td
(PI-based)Tj
3.719 0 Td
(and)Tj
1.7348 0 Td
(NNRTI-based)Tj
5.8677 0 Td
(therapies)Tj
3.8437 0 Td
(were)Tj
2.1203 0 Td
(similar)Tj
2.9877 0 Td
(in)Tj
-35.96 -1.2982 Td
(Pre-CP)Tj
3.1464 0 Td
(and)Tj
1.7291 0 Td
(Post)Tj
1.9446 0 Td
(CP)Tj
1.4456 0 Td
(phases)Tj
2.8403 0 Td
(\(PI:)Tj
1.6838 0 Td
(64.3%)Tj
2.6305 0 Td
(vs)Tj
1.0375 0 Td
(64.9%;)Tj
2.8516 0 Td
(NNRTI:)Tj
3.4923 0 Td
(30.6%)Tj
2.6305 0 Td
(vs)Tj
1.0375 0 Td
(32.0%)Tj
2.6249 0 Td
(respectively;)Tj
-29.0946 -1.3039 Td
(p)Tj
/F13 1 Tf
0 Tc
(>)Tj
/F8 1 Tf
-0.004 Tc
(0.05\).)Tj
3.7247 0 Td
(On)Tj
1.5136 0 Td
(the)Tj
1.474 0 Td
(contrary,)Tj
3.8495 0 Td
(Raltegravir)Tj
4.6091 0 Td
(was)Tj
1.7008 0 Td
(prescribed)Tj
4.4106 0 Td
(as)Tj
1.0148 0 Td
(a)Tj
0.6577 0 Td
(part)Tj
1.8368 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.474 0 Td
(ART)Tj
2.1316 0 Td
(regimen)Tj
3.5433 0 Td
(more)Tj
2.3414 0 Td
(fre-)Tj
-35.2967 -1.2983 Td
(quently)Tj
3.2258 0 Td
(in)Tj
1.0374 0 Td
(the)Tj
1.4684 0 Td
(Pre-CP)Tj
3.1464 0 Td
(\(14.3%\))Tj
3.3108 0 Td
(than)Tj
2.024 0 Td
(in)Tj
1.0374 0 Td
(Post-CP)Tj
3.5207 0 Td
(\(10.8%\))Tj
3.3051 0 Td
(phase)Tj
2.4832 0 Td
(\(p)Tj
1.0771 0 Td
(=)Tj
0.8051 0 Td
(0.008\),)Tj
2.9083 0 Td
(as)Tj
1.0148 0 Td
(well)Tj
1.8255 0 Td
(as)Tj
1.0148 0 Td
(Maraviroc)Tj
-33.2048 -1.2983 Td
(\(3.9%)Tj
2.4944 0 Td
(vs)Tj
1.0318 0 Td
(2.7%,)Tj
2.3811 0 Td
(p)Tj
0.737 0 Td
(=)Tj
0.7994 0 Td
(0.11\).)Tj
2.4378 0 Td
(These)Tj
2.5681 0 Td
(results)Tj
2.8063 0 Td
(are)Tj
1.4513 0 Td
(consistent)Tj
4.2577 0 Td
(with)Tj
1.9955 0 Td
(the)Tj
1.4684 0 Td
(treatment)Tj
4.1385 0 Td
(indications)Tj
4.6715 0 Td
(of)Tj
1.0148 0 Td
(HIV)Tj
2.0182 0 Td
(CP)Tj
-36.2718 -1.3039 Td
(and)Tj
1.7291 0 Td
(the)Tj
1.4683 0 Td
(overall)Tj
2.9027 0 Td
(achievement)Tj
5.2667 0 Td
(of)Tj
1.0148 0 Td
(economic)Tj
4.1386 0 Td
(objectives)Tj
4.1442 0 Td
(of)Tj
1.0148 0 Td
(cost)Tj
1.8085 0 Td
(monitoring:)Tj
5.0456 0 Td
(HIV)Tj
2.0183 0 Td
(CP)Tj
1.4456 0 Td
(discouraged)Tj
-31.9972 -1.2983 Td
(the)Tj
1.4626 0 Td
(Raltegravir)Tj
4.5978 0 Td
(and)Tj
1.7234 0 Td
(Maraviroc)Tj
4.3654 0 Td
(prescription,)Tj
5.3121 0 Td
(only)Tj
1.9672 0 Td
(for)Tj
1.3776 0 Td
(expensiveness)Tj
5.794 0 Td
(reasons)Tj
3.2145 0 Td
(and)Tj
1.7234 0 Td
(only)Tj
1.9729 0 Td
(if)Tj
0.7654 0 Td
(an)Tj
1.1962 0 Td
(alter-)Tj
-35.4725 -1.2982 Td
(native)Tj
2.6362 0 Td
(therapeutic)Tj
4.7281 0 Td
(regimen)Tj
3.532 0 Td
(could)Tj
2.4434 0 Td
(guarantee)Tj
4.1386 0 Td
(to)Tj
1.0148 0 Td
(the)Tj
1.4626 0 Td
(patients)Tj
3.3619 0 Td
(the)Tj
1.4627 0 Td
(same)Tj
2.2507 0 Td
(level)Tj
2.0069 0 Td
(of)Tj
1.0091 0 Td
(effectiveness,)Tj
5.4198 0 Td
(with-)Tj
-35.4668 -1.3039 Td
(out)Tj
1.5533 0 Td
(modifying)Tj
4.3654 0 Td
(the)Tj
1.4683 0 Td
(expected)Tj
3.7247 0 Td
(clinical)Tj
3.0727 0 Td
(outcome,)Tj
3.9515 0 Td
(paying)Tj
2.9083 0 Td
(attention)Tj
3.8438 0 Td
(to)Tj
1.0261 0 Td
(the)Tj
1.4684 0 Td
(presence)Tj
3.7133 0 Td
(of)Tj
1.0148 0 Td
(eventual)Tj
-32.1106 -1.2983 Td
(resistances.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 190.9984 cm
BT
/F0 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Effectiveness)Tj
6.1087 0 Td
(results)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 173.9905 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Undetectable)Tj
5.5105 0 Td
(HIV-RNA)Tj
4.4106 0 Td
(level)Tj
2.0183 0 Td
(at)Tj
0.9524 0 Td
(12-month)Tj
4.2236 0 Td
(follow)Tj
2.6986 0 Td
(up)Tj
1.2642 0 Td
(was)Tj
1.6951 0 Td
(achieved)Tj
3.7021 0 Td
(by)Tj
1.1848 0 Td
(81.2%)Tj
2.6306 0 Td
(of)Tj
1.0148 0 Td
(patients)Tj
3.3675 0 Td
(in)Tj
1.0318 0 Td
(Pre-)Tj
-35.7049 -1.2982 Td
(CP)Tj
1.4399 0 Td
(phase,)Tj
2.7099 0 Td
(and)Tj
1.7292 0 Td
(83.2%)Tj
2.6305 0 Td
(in)Tj
1.0375 0 Td
(Post-CP)Tj
3.5149 0 Td
(\()Tj
0.83 0.64 0.02 0 k
(Table)Tj
2.7836 0 Td
(3)Tj
0 g
(\).)Tj
1.2586 0 Td
(No)Tj
1.4627 0 Td
(statistically)Tj
4.6147 0 Td
(significant)Tj
4.388 0 Td
(differences)Tj
4.5638 0 Td
(emerged,)Tj
-32.1333 -1.2983 Td
(comparing)Tj
4.575 0 Td
(Pre-CP)Tj
3.1465 0 Td
(and)Tj
1.7291 0 Td
(Post-CP)Tj
3.5149 0 Td
(\(p)Tj
1.0772 0 Td
(=)Tj
0.7994 0 Td
(0.12\).)Tj
2.4377 0 Td
(However,)Tj
4.0819 0 Td
(comparing)Tj
4.5694 0 Td
(groups)Tj
2.9707 0 Td
(by)Tj
1.1849 0 Td
(category,)Tj
3.8211 0 Td
(86.9%)Tj
2.6305 0 Td
(of)Tj
-36.5383 -1.3039 Td
(Post-CP)Tj
3.5149 0 Td
(First)Tj
2.4378 0 Td
(Line)Tj
2.3924 0 Td
(population)Tj
4.5921 0 Td
(achieved)Tj
3.6963 0 Td
(undetectable)Tj
5.3065 0 Td
(HIV-RNA)Tj
4.4107 0 Td
(at)Tj
0.9524 0 Td
(12)Tj
1.1735 0 Td
(months,)Tj
/F12 1 Tf
3.5093 0 Td
[()3()2()5()10()-4()]TJ
/F8 1 Tf
2.5908 0 Td
(79.4%)Tj
-34.5767 -1.2983 Td
(in)Tj
1.0318 0 Td
(Pre-CP)Tj
3.1521 0 Td
(phase)Tj
2.4831 0 Td
(\(p)Tj
1.0772 0 Td
(=)Tj
0.7993 0 Td
(0.002\).)Tj
-7.3473 -1.2982 Td
(Mean)Tj
2.5228 0 Td
(Nadir)Tj
2.5568 0 Td
(CD4)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 281.4803 113.4425 cm
BT
/F8 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(+)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 288.0566 109.0204 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(cell)Tj
1.559 0 Td
(counts)Tj
2.8856 0 Td
(were)Tj
2.1203 0 Td
(221)Tj
/F15 1 Tf
1.6498 0 Td
[()]TJ
/F8 1 Tf
(5)Tj
1.2642 0 Td
(cells/mm)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 419.5275 113.4425 cm
BT
/F8 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(3)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 425.3102 109.0204 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(in)Tj
1.0318 0 Td
(Pre-CP)Tj
3.1464 0 Td
(and)Tj
1.7348 0 Td
(233)Tj
/F15 1 Tf
1.6441 0 Td
[()]TJ
/F8 1 Tf
(5)Tj
1.2642 0 Td
(cells/mm)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 550.2614 113.4425 cm
BT
/F8 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(3)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 555.9874 109.0204 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(in)Tj
-35.5972 -1.3039 Td
(Post-CP)Tj
3.5149 0 Td
(Phase,)Tj
2.7496 0 Td
(respectively.)Tj
5.1137 0 Td
(In)Tj
1.1055 0 Td
(the)Tj
1.474 0 Td
(overall)Tj
2.9027 0 Td
(population,)Tj
4.8132 0 Td
(Nadir)Tj
2.5568 0 Td
(CD4)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 461.0834 100.4598 cm
BT
/F8 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(+)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 467.6031 95.9811 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(cell)Tj
1.559 0 Td
(counts)Tj
2.8856 0 Td
(were)Tj
2.126 0 Td
(227)Tj
/F15 1 Tf
1.6441 0 Td
[()]TJ
/F8 1 Tf
0.788 0 Td
(3)Tj
-35.7615 -1.2982 Td
(cells/mm)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 236.6929 87.4204 cm
BT
/F8 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(3)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 240.2645 82.9984 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(.)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 479.8488 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(HIV)Tj
1.8708 0 Td
(Clinical)Tj
3.3662 0 Td
(Pathway)Tj
3.9969 0 Td
(in)Tj
0.9779 0 Td
(Italy)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.4748 0 Td
(DOI:10.137)Tj
5.0387 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.0168)Tj
3.5434 0 Td
(399)Tj
2.6362 0 Td
(December)Tj
4.7622 0 Td
(28,)Tj
1.5874 0 Td
(2016)Tj
36.7515 0 Td
(5)Tj
0.7654 0 Td
(/)Tj
ET
endstream
endobj
78 0 obj
<>stream
endstream
endobj
79 0 obj
<>stream
endstream
endobj
80 0 obj
<>stream
endstream
endobj
81 0 obj
<>stream
endstream
endobj
82 0 obj
<>stream
endstream
endobj
83 0 obj
<>stream
endstream
endobj
84 0 obj
<>stream
endstream
endobj
85 0 obj
<>stream
endstream
endobj
86 0 obj
<>stream
endstream
endobj
87 0 obj
<>stream
BT
66.402 0 Td
(12)Tj
ET
Q
endstream
endobj
88 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 11 0 R/Annots 93 0 R/Contents 94 0 R/TrimBox[0 0 612 792]>>
endobj
92 0 obj
<>
endobj
95 0 obj
<>stream
/CIDInit/ProcSet findresource begin
12 dict begin begincmap
/CMapName/Adobe-Identity-UCS def
/CIDSystemInfo<>def
/CMapType 2 def
1 begincodespacerange
<0000>
endcodespacerange
2 beginbfchar
<001F><003C>
<0021><003E>
endbfchar
endcmap
CMapName currentdict /CMap defineresource pop end end
endstream
endobj
96 0 obj
<>/FontDescriptor 97 0 R/DW 750/W[31[584] 33[584]]>>
endobj
97 0 obj
<>
endobj
98 0 obj
<>stream
cvt ;! \ NfpgmTm6 glyf'( 0 head 6hhea6 $hmtx?8 ! loca x| maxp
prepX } g/_< r¿ ɦg >N CK ! ? Z / U *} t t t t t t t t t t t t t t t t t t t t t t t t t t t t t t t TA 0 O _ @3@_3@NQ2LM2@@H2@
2@ :2@032Ex2@2:2*12@$%2A / ? @2 2@2 @@
2OOA7 _ ? / / ? O o @ , ,@,@ 4@74. C2 C3 G, C C{*H-*H!*D7 @
?*LA : 6 *r -V@J*-*@R{*xln l!@c*Z*ZX N VGE*D*@3-2!1r.,)('l"!@EU
7~A;650/+%
@+ J KKSBKc Kb S#
QZ#BK KTB8+KR7+KP[XY8+ TXCX YY v??>9FD>9FD>9FD>9FD>9F`D>9F`D+++++++++++++++++++++++++KPy X=++KSy X=++KSXY2KSXYKS \XEDEDYX,ERX,DYYKS \X ?EDEDYX ?ERX ?DYYKS \X #ED EDYX #ERX # DYYKS \X ED *EDYX ERX DYYKS \X#ED##EDYX ERX DYYK